Processing 00000000.tx.1: Imaging -Cell Death With a Near-Infrared Probe Zdravka Medarova1, Susan Bonner-Weir2, Myra Lipes2, and Anna Moore1 1 MGH/MIT/HMS Athinoula A. 

Phrase: "Imaging -"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "Cell Death With a Near-Infrared Probe Zdravka Medarova1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0007587:Cell Death [Cell Function]
   742   C0007634:Cell [Cell]
   742   C0011065:Death [Organism Function]
   742   C1269647:Cell [Cell]
   742   C1306577:Death, NOS [Finding]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "Susan Bonner-Weir2,"

Phrase: "Myra Lipes2,"

Phrase: "and"

Phrase: "Anna Moore1 1 MGH/MIT/HMS Athinoula A."
Processing 00000000.tx.2: Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts 2 Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Evidence exists for an essential role of -cell apoptosis in the pathology of type 1 and type 2 diabetes. 

Phrase: "Martinos"

Phrase: "Center for Biomedical Imaging, Department of Radiology,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   778   C0872020:biomedical imaging [Intellectual Product]
   774   C0587500:Radiology department [Health Care Related Organization]
   774   C1708467:Imaging Center [Health Care Related Organization]
   748   C0011923:Imaging [Diagnostic Procedure]
   748   C0034599:Radiology [Biomedical Occupation or Discipline]
   748   C0043299:radiology [Diagnostic Procedure]
   748   C0079595:Imaging [Diagnostic Procedure]
   748   C0205099:Center [Spatial Concept]
   748   C0807679:Radiology [Diagnostic Procedure]
   748   C1704729:Department [Organization]
   748   C1879848:Biomedical [Biomedical Occupation or Discipline]
   748   C1962945:Radiology [Diagnostic Procedure]
   714 E C1704254:Image [Intellectual Product]
   714 E C1704922:Image [Entity]
   714 E C3542466:Image [Intellectual Product]

Phrase: "Massachusetts General Hospital/Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   799   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 2 Joslin Diabetes Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205099:Center [Spatial Concept]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "exists for an essential role of -cell apoptosis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0007634:Cell [Cell]
   744   C0035820:Role [Social Behavior]
   744   C0162638:Apoptosis [Cell Function]
   744   C0205224:Essential [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1705810:Role [Conceptual Entity]
   744   C1948049:Cell [Spatial Concept]
   744   C2987476:Exist [Conceptual Entity]

Phrase: "in the pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "of type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type 1 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.3: Current methods for diabetes-associated apoptosis detection, however, suffer the drawbacks of relying on in situbased strategies. 

Phrase: "Current methods for diabetes-associated apoptosis detection,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0449335:detection methods [Intellectual Product]
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0449851:Methods [Functional Concept]
   714 E C0871511:METHOD [Intellectual Product]

Phrase: "however,"

Phrase: "suffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683278:suffer [Mental or Behavioral Dysfunction]

Phrase: "the drawbacks of relying"

Phrase: "on"

Phrase: "in situbased strategies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategies [Mental Process]
Processing 00000000.tx.4: In this study, we attempted to measure, both in vitro and ex vivo, levels of -cell apoptosis in diabetic mice using Cy5.5-labeled annexin V. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "ex vivo, levels of -cell apoptosis in diabetic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162638:Apoptosis [Cell Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Cy5.5-labeled annexin V."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1332095:ANNEXIN V [Gene or Genome]
   804   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.5: We used streptozotocin-treated BALB/c mice and NOD mice of different ages as models of type 1 diabetes and db/db mice as a model of type 2 diabetes. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "streptozotocin-treated BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0025919:Mice, BALB C [Mammal]
           BALB/C
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "NOD mice of different ages"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0085243:Non-Obese Diabetic Mice [Mammal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0241863:DIABETIC [Finding]

Phrase: "as models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "of type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "db/db mice as a model of type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C2986594:Mouse Model [Experimental Model of Disease]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
Processing 00000000.tx.6: With annexin V Cy5.5, we established differences in levels of apoptosis between diabetic and control animals. 

Phrase: "With annexin V Cy5.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "we"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "differences in levels of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control animals."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C1511501:Control Animal [Animal]
   861   C0003062:Animals [Animal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.7: Intravenously administered annexin V Cy5.5 accumulated in pancreata of diabetic mice but not in nondiabetic controls. 

Phrase: "Intravenously administered annexin V Cy5.5"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   827   C1332095:ANNEXIN V [Gene or Genome]
   799   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C1521801:Administered [Functional Concept]
   766 E C1621583:Administer [Functional Concept]

Phrase: "accumulated in pancreata of diabetic mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0241863:DIABETIC [Finding]
   750   C1518865:Mouse Pancreas [Tissue]
   719   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   719   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "not in nondiabetic controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1518422:Not [Functional Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.8: Furthermore, its localization was specific to apoptotic events within diabetic islets; 

Phrase: "Furthermore,"

Phrase: "its localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "specific to apoptotic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "within diabetic islets"

Phrase: ";"
Processing 00000000.tx.9: its selectivity was supported by transferase-mediated dUTP nick-end labeling staining. 

Phrase: "its selectivity"

Phrase: "was"

Phrase: "supported by transferase-mediated dUTP nick-end labeling staining."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0444930:End [Spatial Concept]
   742   C0487602:Staining [Laboratory Procedure]
   742   C1167624:Labeling [Mental Process]
   742   C1521721:Supported [Conceptual Entity]
   742   C1704680:Staining [Finding]
   742   C1947902:Labeling [Manufactured Object]
   742   C2746065:End [Temporal Concept]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   734   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   708 E C0183683:Support [Medical Device]
Processing 00000000.tx.10: Because annexin V defines an early marker of apoptosis and the developed probe is suitable for in vivo administration, it may provide a promising tool for real-time identification in intact animals of the earliest stages of diabetes-associated -cell death and for tracing the events that characterize the pathology of the disease. 

Phrase: "Because"

Phrase: "annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "defines"

Phrase: "an early marker of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "the developed probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "is"

Phrase: "suitable for in vivo administration,"

Phrase: "it"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a promising tool for real-time identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0336791:Tool [Manufactured Object]
   748   C2827396:Tool [Manufactured Object]

Phrase: "in intact animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "of the earliest stages"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2363430:early stages [Temporal Concept]
   966 E C1517886:Early Stage [Classification]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of diabetes-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "associated -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and for tracing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "the events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "that"

Phrase: "characterize"

Phrase: "the pathology of the disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.11: In recent years, evidence has been accumulating that apoptosis is a central event contributing to type 1 and type 2 diabetes. 

Phrase: "In recent years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "accumulating"

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "a central event contributing to type 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contributing [Activity]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.12: In fact, the process of -cell death appears to constitute a major link between the seemingly distinct disease pathways. 

Phrase: "In fact,"

Phrase: "the process of -cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "constitute"

Phrase: "a major link between the seemingly distinct disease pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1517892:Link [Intellectual Product]
   742   C1704666:Link [Intellectual Product]
Processing 00000000.tx.13: Whereas type 1 diabetes is characterized by the specific autoimmune recognition and destruction of insulin-producing -cells, the signals mediating -cell destruction in type 2 diabetes are less clear but may be metabolic. 

Phrase: "Whereas"

Phrase: "type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "characterized by the specific autoimmune recognition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205369:Specific [Qualitative Concept]
   753   C0443146:Autoimmune [Pathologic Function]
   753   C0524637:Recognition [Mental Process]
   753   C1552740:specific [Intellectual Product]
   753   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "destruction of insulin-producing -cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261381:Destruction [Therapeutic or Preventive Procedure]
   760   C1948029:Destruction [Activity]

Phrase: "the signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "mediating -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "cell destruction in type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261381:Destruction [Therapeutic or Preventive Procedure]
   753   C1948029:Destruction [Activity]

Phrase: "are"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "be"

Phrase: "metabolic."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]
Processing 00000000.tx.14: Type 1 diabetesassociated autoimmunity appears to be primarily a T-cellmediated process. 

Phrase: "Type 1 diabetesassociated autoimmunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0004368:Autoimmunity [Pathologic Function]
   741 E C0443146:Autoimmune [Pathologic Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "primarily a T-cellmediated process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1184743:Process [Body Part, Organ, or Organ Component]
   804   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.15: Current theories implicate the process of neonatal -cell remodeling, which is associated with a wave of apoptosis, as a potential source of initiating autoantigen (1,2). 

Phrase: "Current theories"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871935:theories [Idea or Concept]

Phrase: "implicate"

Phrase: "the process of neonatal -cell remodeling,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0007613:Cell Process [Cell Function]
   783   C0230625:Cell process [Cell Component]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1522240:Process [Phenomenon or Process]

Phrase: "which"

Phrase: "is"

Phrase: "associated with a wave of apoptosis,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C2599617:A wave [Organism Attribute]
   753   C0162638:Apoptosis [Cell Function]
   753   C0678544:wave [Natural Phenomenon or Process]
   753   C1421479:WAVE [Gene or Genome]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as"

Phrase: "a potential source of initiating autoantigen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Extensive evidence of -cell death in type 1 diabetes has been gathered using a variety of model systems, including the NOD mouse (3) and the multiple low-dose streptozotocin (MLDS) model (1,4,5). 

Phrase: "Extensive evidence of -cell death in type 1 diabetes"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   784   C0449475:Type of cell [Intellectual Product]
           cell type
   764   C0007587:Cell Death [Cell Function]
   762   C0007634:Cell Type [Cell]
           Cell
   742   C0011065:Death [Organism Function]
   742   C1269647:Cell [Cell]
   742   C1306577:Death, NOS [Finding]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "gathered"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a variety of model systems,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the NOD mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mouse [Mammal]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "the multiple low-dose streptozotocin (MLDS) model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.17: Transgenic mouse models have been particularly useful in unraveling the complex molecular interactions accompanying -cell death in type 1 diabetes (6,7). 

Phrase: "Transgenic mouse models"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C1519606:Transgenic Model [Experimental Model of Disease]
   884   C2986594:Mouse Model [Experimental Model of Disease]
   827   C3161035:Models [Intellectual Product]
   734   C0025936:Mouse, Transgenic [Mammal]

Phrase: "have"

Phrase: "been"

Phrase: "particularly useful in unraveling"

Phrase: "the complex molecular interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1167622:Molecular Interaction [Molecular Function]
   793   C1704675:Interaction [Functional Concept]

Phrase: "accompanying -"

Phrase: "cell death in type 1 diabetes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007587:Cell Death [Cell Function]
   783   C0007634:Cell Type [Cell]
           Cell
   783   C0449475:cell type [Intellectual Product]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.18: Evidence exists for direct killing of -cells by T-cells through the perforin/granzyme pathway (8,9) and Fas/FasL interaction (10,11), as well as for -cell destruction through soluble mediators, the most important being interleukin-1 (12), tumor necrosis factor- (13), and interferon- (14,15). 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "exists for direct"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439851:Direct [Qualitative Concept]
   790   C1947931:Direct [Qualitative Concept]
   790   C2987476:Exist [Conceptual Entity]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "of -cells by T-cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0039194:T-Cells [Cell]

Phrase: "through the perforin/granzyme pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: "and"

Phrase: "Fas/FasL interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "(10,"

Phrase: "11"

Phrase: ")"

Phrase: ","

Phrase: "as well as for -cell destruction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0007634:Cell [Cell]
   753   C0205170:Well [Qualitative Concept]
   753   C1261381:Destruction [Therapeutic or Preventive Procedure]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948029:Destruction [Activity]
   753   C1948049:Cell [Spatial Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "through soluble mediators,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   827 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the most important"

Phrase: "being"

Phrase: "interleukin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "tumor necrosis factor-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "interferon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.19: Insulin resistance, the increasing need for higher levels of insulin in order to have glucose uptake in target tissues, is a hallmark of type 2 diabetes (16). 

Phrase: "Insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the increasing need for higher levels of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0027552:Need [Qualitative Concept]
   744   C0686904:need [Functional Concept]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "have"

Phrase: "glucose uptake in target tissues,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1159527:glucose uptake [Cell Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "is"

Phrase: "a hallmark of type 2 diabetes"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.20: Type 2 diabetes develops when there is inadequate compensation for insulin resistance (16). 

Phrase: "Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "develops"

Phrase: "when"

Phrase: "there"

Phrase: "is"

Phrase: "inadequate compensation for insulin resistance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0152057:Compensation [Mental Process]
   760   C0152058:Compensation [Physiologic Function]
   760   C0220808:Compensation [Quantitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.21: The main compensatory mechanisms to insulin resistance are enhanced function of the -cells and an increase in -cell mass, resulting from a shift in the balance between -cell renewal (proliferation and neogenesis) and -cell apoptosis. 

Phrase: "The main compensatory mechanisms to insulin resistance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C1522618:resistance mechanism [Clinical Attribute]
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "function of the -cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   819   C0007613:cells function [Cell Function]
   770   C0007634:Cells [Cell]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "an increase in -cell mass,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "resulting from a shift"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0333051:Shift [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C2347509:Shift [Phenomenon or Process]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in the balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014653:Balance [Organism Function]
  1000   C0205415:Balance [Functional Concept]
  1000   C0560184:Balance [Finding]

Phrase: "between -cell renewal"

Phrase: "(proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "neogenesis"

Phrase: ")"

Phrase: "and -"

Phrase: "cell apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.22: In animal models, increased -cell apoptosis has been associated with glucotoxicity (1719), lipotoxicity (2023), formation of amyloid deposits (2426), and/or genetic factors associated with defects in insulin signal transduction (27). 

Phrase: "In animal models,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "increased -"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "associated with glucotoxicity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(1719"

Phrase: ")"

Phrase: ","

Phrase: "lipotoxicity"

Phrase: "(2023"

Phrase: ")"

Phrase: ","

Phrase: "formation of amyloid deposits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "(2426"

Phrase: ")"

Phrase: ","

Phrase: "and/or"

Phrase: "genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "associated with defects"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0243067:defects [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1457869:Defect [Functional Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   756 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in insulin signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.23: Recent evidence from autopsied human pancreata suggests an increased frequency of -cell apoptosis in cases of diabetes compared with nondiabetic control subjects (28). 

Phrase: "Recent evidence from autopsied human pancreata"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an increased frequency of -cell apoptosis in cases of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0162638:Apoptosis [Cell Function]

Phrase: "compared with nondiabetic control subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.24: Metabolic/environmental factors influence the need for insulin secretion continually throughout the life of an organism. 

Phrase: "Metabolic/environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1516998:Environmental Factors [Functional Concept]
   884 E C0686732:Environmental Factor [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "influence"

Phrase: "the need for insulin secretion continually"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0027552:Need [Qualitative Concept]
   753   C0686904:need [Functional Concept]

Phrase: "throughout the life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]

Phrase: "of an organism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029235:Organism [Organism]
Processing 00000000.tx.25: The need to respond to ever-changing energy demands requires insulin secretion by the -cell to be a tightly regulated process. 

Phrase: "The need to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Need [Qualitative Concept]
   861   C0686904:need [Functional Concept]

Phrase: "respond"

Phrase: "to ever-changing energy demands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441516:demands [Therapeutic or Preventive Procedure]
   804   C0699784:demands [Idea or Concept]

Phrase: "requires"

Phrase: "insulin secretion by the -cell to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   820   C1327616:secretion by cell [Cell Function]
           Cell secretion
   790   C1256369:insulin secretion [Cell Function]
   783   C0030281:Insulin Cell [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "be"

Phrase: "a tightly regulated process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.26: In type 1 and type 2 diabetes, the delicate balance of cell renewal and cell loss is disrupted. 

Phrase: "In type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type 1 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "the delicate balance of cell renewal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0014653:Balance [Organism Function]
   753   C0205415:Balance [Functional Concept]
   753   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "cell loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "disrupted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]
Processing 00000000.tx.27: Therefore, the ability to detect the earliest stages of -cell apoptosis and to quantify -cell death in vivo would be instrumental in understanding the time course of the disease and in designing new potential therapeutic strategies. 

Phrase: "Therefore,"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the earliest stages of -cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "would"

Phrase: "be"

Phrase: "instrumental in understanding"

Phrase: "the time course of the disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0449247:Time course [Temporal Concept]
   783   C0242656:disease course [Pathologic Function]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "and in designing new potential therapeutic strategies."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   748   C0205314:New [Temporal Concept]
   748   C0302350:Therapeutic [Functional Concept]
   748   C0679199:strategies [Mental Process]
   748   C1515981:And [Idea or Concept]
   748   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.28: To date, the evidence of diabetes-associated -cell apoptosis has been almost exclusively based on histological detection, namely microscopic identification of morphological changes associated with apoptosis, transferase-mediated dUTP nick-end labeling (TUNEL), and active caspase-3 detection. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "the evidence of diabetes-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "associated -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "almost exclusively"

Phrase: "based on histological detection,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205462:Histological [Functional Concept]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "namely microscopic identification of morphological changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "associated with apoptosis,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0162638:Apoptosis [Cell Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "transferase-mediated dUTP nick-end labeling (TUNEL),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "active caspase-3 detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.29: The first method relies on recognition of events such as membrane blebbing, cell shrinkage, and nuclear condensation, whereas TUNEL identifies DNA fragmentation and can be positive for either apoptosis or necrosis. 

Phrase: "The first method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "relies on recognition of events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441471:Events [Event]
   760   C0524637:Recognition [Mental Process]
   760   C3541888:Events [Classification]

Phrase: "such as membrane blebbing,"

Phrase: "cell shrinkage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332513:Shrinkage [Functional Concept]

Phrase: "and"

Phrase: "nuclear condensation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "whereas"

Phrase: "TUNEL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "identifies"

Phrase: "DNA fragmentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "positive for either apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "or"

Phrase: "necrosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]
Processing 00000000.tx.30: A recent study explored the possibility for apoptosis detection in a cyclophosphamide-accelerated NOD model of diabetes using caspase-3 labeling (29), but virtually no -cell death was identified even at the height of -cell loss, presumably because of the rapid clearing of dying -cells. 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "explored"

Phrase: "the possibility for apoptosis detection"

Phrase: "in a cyclophosphamide-accelerated NOD model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "labeling"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]
   966 E C0181496:Label [Manufactured Object]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "virtually no -cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "even at the height of -cell loss,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0424641:Loss of height [Finding]
           height loss
   748   C0007634:Cell [Cell]
   748   C0489786:Height [Organism Attribute]
   748   C1269647:Cell [Cell]
   748   C1517945:Loss [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "presumably because of the rapid clearing of dying -cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   742   C0007634:Cells [Cell]
   742   C0184532:dying [Organism Function]
   742   C0439831:Rapid [Qualitative Concept]
   742   C1550003:Clearing [Idea or Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.31: In addition, the cyclophosphamide-treated 13-week-old NOD mouse model reflects a rather advanced stage of the disease. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the cyclophosphamide-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0010583:Cyclophosphamide [Organophosphorus Compound,Pharmacologic Substance]
   944 E C0699319:Cytoxan [Organophosphorus Compound,Pharmacologic Substance]
   944 E C0699320:Endoxan [Organophosphorus Compound,Pharmacologic Substance]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "13-week-old NOD mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C2986594:Mouse Model [Experimental Model of Disease]
   795   C3161035:Model [Intellectual Product]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a rather advanced stage of the disease."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   774   C0679246:advanced disease [Finding]
   774   C0699749:disease stage [Diagnostic Procedure]
   748   C0205179:Advanced [Qualitative Concept]
   748   C0205390:Stage [Temporal Concept]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   714 E C0725066:Advance [Medical Device]
Processing 00000000.tx.32: Many attempts to identify apoptotic events associated with diabetes have been hampered by the rapid clearing of dying -cells as well as a long time course of the disease. 

Phrase: "Many attempts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516084:Attempt [Event]

Phrase: "identify"

Phrase: "apoptotic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "associated with diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "hampered by the rapid clearing of dying -cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0007634:Cells [Cell]
   744   C0184532:dying [Organism Function]
   744   C0439831:Rapid [Qualitative Concept]
   744   C1550003:Clearing [Idea or Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "as well as"

Phrase: "a long time course of the disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0449247:Time course [Temporal Concept]
   774   C0242656:disease course [Pathologic Function]
   748   C0040223:Time [Temporal Concept]
   748   C0750729:Course [Temporal Concept]
   748   C3541383:Time [Temporal Concept]
Processing 00000000.tx.33: Therefore, novel approaches for the detection of early apoptosis would clearly contribute to our study of the progression of diabetes. 

Phrase: "Therefore,"

Phrase: "novel approaches for the detection of early apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449445:Approaches [Spatial Concept]
   744   C1292724:Approaches [Functional Concept]

Phrase: "would"

Phrase: "clearly"

Phrase: "contribute to our study of the progression of diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0242656:progression [Pathologic Function]
   742   C0449258:Progression [Functional Concept]
   742   C0557651:Study [Manufactured Object]
   742   C1880177:Contribute [Activity]
   742   C2603343:Study [Research Activity]
Processing 00000000.tx.34: One of the earliest markers of apoptosis is the externalization of phosphatidylserine, an aminophospholipid normally found exclusively on the cytoplasmic leaflet of the plasma membrane. 

Phrase: "One of the earliest markers of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "the externalization of phosphatidylserine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   909   C2753858:externalization of phosphatidylserine [Cell Function]

Phrase: "an aminophospholipid normally"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "exclusively on the cytoplasmic leaflet of the plasma membrane."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0007603:Plasma membrane [Cell Component]
           Cytoplasmic Membrane
   742   C0010834:Cytoplasmic [Cell Component]
   742   C0025255:Membrane [Tissue]
   742   C0032105:Plasma [Body Substance]
   742   C0521449:Cytoplasmic [Body Location or Region]
   742   C0596901:Membrane [Cell Component]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1706182:Membrane [Manufactured Object]
   742   C1708664:Leaflet [Manufactured Object]
   742   C3273178:Leaflet [Intellectual Product]
Processing 00000000.tx.35: The externalization of phosphatidylserine makes it available for recognition by exogenous annexin V, a naturally occurring calcium-dependent 35-kDa protein that binds with high avidity (Kd = 110 mol/l) to membrane-associated aminophospholipids (30,31). 

Phrase: "The externalization of phosphatidylserine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   909   C2753858:externalization of phosphatidylserine [Cell Function]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it available for recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "by exogenous annexin V,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332095:ANNEXIN V [Gene or Genome]
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a naturally"

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "calcium-dependent 35-kDa protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C0805431:Calcium/Protein [Quantitative Concept]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "binds with high avidity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205250:High [Qualitative Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1299351:High [Qualitative Concept]
   770   C1510996:Avidity [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "(Kd = 110 mol/l) to membrane-associated aminophospholipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0347982:mol/L [Quantitative Concept]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.36: Annexin V labeled with a fluorescent tag is routinely used for histological and cell-sorting studies to identify apoptotic cells (32). 

Phrase: "Annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "labeled with a fluorescent tag"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0037293:Tag [Neoplastic Process]
   760   C0181496:Tag [Manufactured Object]
       E   Label
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1708632:Labeled [Qualitative Concept]
   760   C1710492:TAG [Gene or Genome]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "is"

Phrase: "routinely"

Phrase: "used for histological"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0205462:Histological [Functional Concept]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
   718 E C0019638:Histology [Biomedical Occupation or Discipline]
   718 E C0344441:Histology [Laboratory Procedure]

Phrase: "and"

Phrase: "cell-sorting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007616:Cell Sorting [Laboratory Procedure]
   861   C0237886:Sorting [Mental Process]
   861   C0700314:sorting [Cell Function]
   861   C1947906:Sorting [Activity]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.37: In vivo, annexin has been conjugated to technetium-99m (99mTc) for scintigraphy (3336), superparamagnetic iron oxide nanoparticles for apoptosis detection by magnetic resonance imaging (37), and the Cy5.5 fluorescent dye for near-infrared optical imaging (38,39). 

Phrase: "In vivo, annexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "conjugated to technetium-99m"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0303611:Technetium 99m [Indicator, Reagent, or Diagnostic Aid]
   770   C0039411:Technetium [Element, Ion, or Isotope]
   770   C0522529:Conjugated [Spatial Concept]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(99mTc"

Phrase: ")"

Phrase: "for scintigraphy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034606:Scintigraphy [Diagnostic Procedure]

Phrase: "(3336"

Phrase: ")"

Phrase: ","

Phrase: "superparamagnetic iron oxide nanoparticles for apoptosis detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1450054:Nanoparticles [Manufactured Object]

Phrase: "by magnetic resonance imaging"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0024485:Magnetic Resonance Imaging [Diagnostic Procedure]
  1000   C1552358:Magnetic Resonance Imaging [Professional or Occupational Group]
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0011923:Imaging [Diagnostic Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0079595:Imaging [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   793 E C1704254:Image [Intellectual Product]
   793 E C1704922:Image [Entity]
   793 E C3542466:Image [Intellectual Product]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Cy5.5 fluorescent dye for near-infrared optical imaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]
   739   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.38: The success of imaging apoptosis using labeled annexin V and the fact that phosphatidylserine externalization is an early apoptotic event prompted us to investigate the potential of a Cy5.5-conjugated annexin V probe for the detection of -cell death in diabetes. 

Phrase: "The success of imaging apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597535:Success [Social Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "labeled annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332095:ANNEXIN V [Gene or Genome]
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the fact"

Phrase: "that phosphatidylserine externalization"

Phrase: "is"

Phrase: "an early apoptotic event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441471:Event [Event]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the potential of a Cy5.5-conjugated annexin V probe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3245505:Potential [Qualitative Concept]

Phrase: "for the detection of -cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.39: In this study, we demonstrate the successful localization of annexin V Cy5.5 to apoptotic cells in diabetic islets using several model systems of type 1 and type 2 diabetes. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "the successful localization of annexin V Cy5.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "to apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in diabetic islets"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "several model systems of type 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0026339:Model System [Intellectual Product,Research Device]
   773   C3161035:Model System [Intellectual Product]
   719   C0449913:System [Functional Concept]
   719   C1553451:System [Manufactured Object]
   719   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.40: Our results establish the feasibility of using fluorescently labeled annexin V for detection of the earliest stages of diabetes-associated -cell death.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the feasibility of"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescently labeled annexin V for detection of the earliest stages of diabetes-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1332095:ANNEXIN V [Gene or Genome]
   736   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.41: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  In this study we used different animal models of diabetes. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  In this study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different animal models of diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0599779:Models, Animal [Animal]
   760   C0003062:Animal [Animal]
   760   C3161035:Models [Intellectual Product]
Processing 00000000.tx.42: The MLDS model of type 1 diabetes involves intraperitoneal injections of streptozotocin (STZ) into 6-week-old BALB/c mice at a concentration of 40 mg  kg body wt1  day1 for 5 consecutive days (1). 

Phrase: "The MLDS model of type 1 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3161035:Model [Intellectual Product]

Phrase: "involves"

Phrase: "intraperitoneal injections of streptozotocin (STZ)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0021493:Injections, Intraperitoneal [Therapeutic or Preventive Procedure]
   770   C0021485:injections [Therapeutic or Preventive Procedure]
   770   C0442120:Intraperitoneal [Spatial Concept]
   770   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   770   C1828121:Injections [Functional Concept]
   737 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "into 6-week-old BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025919:Mice, BALB C [Mammal]
           BALB/C
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 40 mg  kg body wt1  day1"

Phrase: "for 5 consecutive days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1442466:5 Days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.43: The single high-dose STZ (SHDS) model involves an intraperitoneal injection of 300 mg STZ/kg body wt into 10-week-old BALB/c mice (Charles River Laboratories, Wilmington, MA). 

Phrase: "The single high-dose STZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "(SHDS"

Phrase: ")"

Phrase: "model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "involves"

Phrase: "an intraperitoneal injection of 300 mg STZ/kg body wt"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   739   C0021485:injection [Therapeutic or Preventive Procedure]
   739   C0442120:Intraperitoneal [Spatial Concept]
   739   C1272883:Injection [Biomedical or Dental Material]
   739   C1533685:Injection [Therapeutic or Preventive Procedure]
   739   C1828121:Injection [Functional Concept]

Phrase: "into 10-week-old BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025919:Mice, BALB C [Mammal]
           BALB/C
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "(Charles River Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Wilmington,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.44: Apoptosis in both models was evaluated 48 h after the last STZ injection. 

Phrase: "Apoptosis in both models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "48 h after the last STZ injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.45: In addition, we investigated type 1 diabetesassociated apoptosis in NOD mice (The Jackson Laboratory, Bar Harbor, ME) at 3, 6, 8, and 12 weeks of age. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "type 1 diabetesassociated apoptosis in NOD mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]

Phrase: "("

Phrase: "The Jackson Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME) at 3,"

Phrase: "6,"

Phrase: "8,"

Phrase: "and"

Phrase: "12 weeks of age."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.46: Type 2 diabetesassociated cell death was investigated using 8-week-old BKS.Cg-m+/+Leprdb/J (db/db) mice; 

Phrase: "Type 2 diabetesassociated cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0449475:type cell [Intellectual Product]
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "8-week-old BKS.Cg-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   804   C3540479:CG [Gene or Genome]

Phrase: "m+/+"

Phrase: "Leprdb/J (db/db) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.47: age-matched background strain (C57BLKS/J) mice were used as controls. 

Phrase: "age-matched background strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0080194:Strain [Injury or Poisoning]
   812   C0456178:strain [Intellectual Product]
   812   C1518614:Strain [Organism]
   812   C2987481:Strain [Mental Process]

Phrase: "(C57BLKS/J) mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1511371:C57BLKS/J Mouse [Mammal]
           C57BLKS/J
   896   C1511372:C57BLKS Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.48: On this background, the db/db mutation results in diabetes. 

Phrase: "On this background,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "the db/db mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "results in diabetes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
Processing 00000000.tx.49: Blood glucose was measured by tail snip in fed state at 10:00 A.M. daily using Glucometer Elite XL (Bayer, Elkhart, IN). 

Phrase: "Blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "measured by tail snip"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   770   C0444706:Measured [Qualitative Concept]
   770   C1835838:SNIP [Gene or Genome]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "in fed state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "at 10"

Phrase: ":"

Phrase: "00 A.M. daily"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332173:Daily [Temporal Concept]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Glucometer Elite XL"

Phrase: "(Bayer,"

Phrase: "Elkhart,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.50: Islet isolation and flow cytometric analysis of isolated primary pancreatic -cells. 

Phrase: "Islet isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "flow cytometric analysis of isolated primary pancreatic -cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
Processing 00000000.tx.51: Pancreatic islet isolation was performed as described by Montana et al. 

Phrase: "Pancreatic islet isolation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0204727:Isolation [Therapeutic or Preventive Procedure]
   827   C0205409:Isolation [Functional Concept]
   827   C0220862:isolation [Laboratory Procedure]
   755 E C1548221:Isolated [Idea or Concept]
   734   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Montana et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026506:Montana [Geographic Area]
   760   C1552738:described [Idea or Concept]
   760   C1948075:Montana [Eukaryote]
Processing 00000000.tx.52: (40) using STZ-treated and control BALB/c mice, NOD mice of the specified ages, and 8-week-old db/db mice and controls. 

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "STZ-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "control BALB/c mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0025919:Mice, BALB C [Mammal]
           BALB/C
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "NOD mice of the specified ages,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0085243:Non-Obese Diabetic Mice [Mammal]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "8-week-old db/db mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.53: The capacity of annexin V Cy5.5 to differentiate between apoptotic and nonapoptotic -cells was evaluated by fluorescence-activated cell sorting (FACS). 

Phrase: "The capacity of annexin V Cy5.5 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1516240:Capacity [Quantitative Concept]

Phrase: "differentiate between apoptotic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205615:differentiate [Qualitative Concept]
   790   C1516044:Apoptotic [Qualitative Concept]
   718 E C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "nonapoptotic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "evaluated by fluorescence-activated cell sorting (FACS)."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   882   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   790   C0007616:Cell Sorting [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0220825:Evaluated [Functional Concept]
   753   C0237886:Sorting [Mental Process]
   753   C0700314:sorting [Cell Function]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1879547:Activated [Activity]
   753   C1947906:Sorting [Activity]
   753   C1948049:Cell [Spatial Concept]
   719 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.54: Briefly, isolated islets of Langerhans were dispersed by trypsin-DNase digestion for 15 min at 37C. 

Phrase: "Briefly,"

Phrase: "isolated islets of Langerhans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets

Phrase: "were"

Phrase: "dispersed by trypsin-DNase digestion"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C2348822:Trypsin Digestion [Research Activity]
   760   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0012238:Digestion [Organism Function]
   760   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0332624:Dispersed [Spatial Concept]
   760   C2349986:Digestion [Research Activity]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.55: After cell count adjustment to 1 x 105 cells per reaction, islet-derived cells were coincubated at 4C for 30 min with a 1:50 dilution of insulin-specific polyclonal rabbit antiserum (MP Biomedicals, Aurora, OH), followed by a fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA) and a 1:20 dilution of annexin V Cy5.5 (BD Pharmingen, San Diego, CA). 

Phrase: "After cell count adjustment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0376209:Adjustment [Individual Behavior]
   827   C0456081:Adjustment [Functional Concept]
   827   C0683269:adjustment [Individual Behavior]
   734   C0007584:Cell Count [Laboratory Procedure]

Phrase: "to 1 x 105 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "per reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "islet-derived cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   913   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   896 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "coincubated at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0450376:4c [Intellectual Product]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "with a 1"

Phrase: ":"

Phrase: "50 dilution of insulin-specific polyclonal rabbit antiserum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079240:Dilution [Laboratory Procedure]
   744   C1948037:Dilution [Functional Concept]

Phrase: "(MP Biomedicals,"

Phrase: "Aurora,"

Phrase: "OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "followed by a fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   760   C0332283:Followed by [Temporal Concept]
           followed
   757   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0018019:goat [Mammal]
   739   C0034493:Rabbit [Mammal]
   739   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0124209:Isothiocyanate [Organic Chemical]
   739   C0206359:isothiocyanate [Organic Chemical]
   739   C0522529:Conjugated [Spatial Concept]
   739   C1265549:goat [Mammal]
   739   C1510458:Goat [Mammal]
   706 E C1719822:Follow [Intellectual Product]

Phrase: "(Vector Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Burlingame,"

Phrase: "CA)"

Phrase: "and"

Phrase: "a 1"

Phrase: ":"

Phrase: "20 dilution of annexin V Cy5.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079240:Dilution [Laboratory Procedure]
   748   C1948037:Dilution [Functional Concept]

Phrase: "(BD Pharmingen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.56: An additional control designed to distinguish dying lymphocytes from dying -cells used flow cytometry of islet cells from 8-week-old NOD mice, labeled with annexin V Cy5.5 and a hamster FITC-conjugated anti-mouse CD3 monoclonal antibody (Cedarlane Laboratories, Hornby, Ontario, Canada). 

Phrase: "An additional control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish"

Phrase: "dying lymphocytes from dying -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0024264:Lymphocytes [Cell]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "flow cytometry of islet cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0016263:Flow Cytometry [Laboratory Procedure]
   760   C0806140:Flow [Natural Phenomenon or Process]
   760   C0814048:Cytometry [Laboratory Procedure]

Phrase: "from 8-week-old NOD mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0085243:Non-Obese Diabetic Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0241863:DIABETIC [Finding]

Phrase: "labeled with annexin V Cy5.5"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "a hamster FITC-conjugated anti-mouse CD3 monoclonal antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   843   C0879551:Anti-CD3 Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   842   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   834   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   807   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   791   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   791   C0746619:monoclonal [Finding]

Phrase: "(Cedarlane Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Hornby,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.57: Separate incubation to assess cell viability was performed with the vital dye 7-amino-actinomycin (7-AAD; BD Pharmingen, San Diego, CA). 

Phrase: "Separate incubation to"

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "performed with the vital dye 7-amino-actinomycin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0001259:Actinomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   744   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   744   C0442732:Vital [Qualitative Concept]
   744   C0884358:Performed [Functional Concept]
   744   C1875856:VITAL [Food]
   744   C3536807:Actinomycin [Pharmacologic Substance]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(7-AAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0049832:7-AAD [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "; BD Pharmingen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.58: Samples were analyzed using the Cell Quest software package (Becton Dickinson, San Diego, CA). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Cell Quest software package"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013194:Package [Medical Device]
   812   C2700580:Package [Manufactured Object]

Phrase: "(Becton Dickinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.59: Ex vivo optical imaging. 

Phrase: "Ex vivo optical imaging."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   812   C0011923:Imaging [Diagnostic Procedure]
   812   C0079595:Imaging [Diagnostic Procedure]
   779 E C1704254:Image [Intellectual Product]
   779 E C1704922:Image [Entity]
   779 E C3542466:Image [Intellectual Product]
   756   C0042789:Vision [Organism Function]
   756   C2707266:Vision [Clinical Attribute]
Processing 00000000.tx.60: For ex vivo near-infrared fluorescence (NIRF) imaging, mice were anesthetized by intraperitoneal injection of a ketamine-xylazine mixture (80 mg/kg/12 mg/kg; Parke-Davis, Morris Plains, NJ [ketamine]; Miles, Shawnee Mission, KS [xylazine]). 

Phrase: "For ex vivo near-infrared fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(NIRF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416389:NIRF [Gene or Genome]
  1000   C1421349:NIRF [Gene or Genome]

Phrase: ")"

Phrase: "imaging, mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "anesthetized by intraperitoneal injection of a ketamine-xylazine mixture"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   742   C0021485:injection [Therapeutic or Preventive Procedure]
   742   C0022614:Ketamine [Organic Chemical,Pharmacologic Substance]
   742   C0043366:Xylazin [Organic Chemical,Pharmacologic Substance]
   742   C0439962:Mixture [Substance]
   742   C0442120:Intraperitoneal [Spatial Concept]
   742   C1272883:Injection [Biomedical or Dental Material]
   742   C1533685:Injection [Therapeutic or Preventive Procedure]
   742   C1720436:Anesthetized [Finding]
   742   C1828121:Injection [Functional Concept]

Phrase: "(80 mg/kg/12 mg/kg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1319635:kg/kg [Quantitative Concept]
           mg/mg

Phrase: "; Parke-Davis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331885:Parke-Davis [Health Care Related Organization]

Phrase: "Morris Plains,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: "[ketamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022614:Ketamine [Organic Chemical,Pharmacologic Substance]

Phrase: "]"

Phrase: "; Miles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0331865:Miles [Quantitative Concept]
   966 E C2347127:mile [Quantitative Concept]
   966 E C2348616:mile [Quantitative Concept]

Phrase: "Shawnee Mission,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026219:Mission [Organization]

Phrase: "KS [xylazine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043366:Xylazin [Organic Chemical,Pharmacologic Substance]

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.61: Annexin V was obtained from Biovision (Mountain View, CA). 

Phrase: "Annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "obtained from Biovision"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Mountain View,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "CA)."
Processing 00000000.tx.62: Annexin V Cy5.5 (synthesized and tested as described in 38) was injected intravenously via the tail vein (50 g/animal). 

Phrase: "Annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "("

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "as"

Phrase: "described in 38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously via the tail vein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2985205:Tail Vein [Body Part, Organ, or Organ Component]
   760   C0039259:Tail [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "(50 g/animal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2348877:g/animal [Quantitative Concept]
   827   C0003062:Animal [Animal]

Phrase: ")."
Processing 00000000.tx.63: Six hours postinjection, animals were killed and pancreata were removed and imaged ex vivo using a whole-body imaging system (Imaging Station IS2000MM; Kodak Scientific Imaging System, New Haven, CT) equipped with a band-pass filter set and near-infrared filter set (Omega Optical, Brattelboro, VT) connected to a Macintosh G4 computer equipped with Kodak ID3.6.3 network version imaging software. 

Phrase: "Six hours postinjection, animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   966   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "imaged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "ex vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348480:ex vivo [Functional Concept]
   861   C1515655:vivo [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a whole-body imaging system"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   875   C0392912:Body system [Body System]
   875   C0460002:body system [Body System]
   875   C2981608:Body System [Functional Concept]
   861   C2697665:Imaging System [Manufactured Object]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   756   C0203669:Whole Body Imaging [Diagnostic Procedure]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Imaging Station IS2000MM"

Phrase: "; Kodak Scientific Imaging System,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C2697665:Imaging System [Manufactured Object]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "New Haven,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205314:New [Temporal Concept]

Phrase: "CT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "equipped with a band-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0230715:A band [Cell Component]
   770   C0175723:Band [Medical Device]
   770   C0439645:Band [Spatial Concept]
   770   C1521913:band [Cell Component]

Phrase: "pass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Pass [Finding]

Phrase: "filter set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "near-infrared filter set (Omega Optical, Brattelboro,"

Phrase: "VT)"

Phrase: "connected to a Macintosh G4 computer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0009622:Computer [Manufactured Object]
   753   C0453947:Mackintosh [Manufactured Object]
   719   C2986575:Connect [Activity]

Phrase: "equipped with Kodak ID3.6.3 network version imaging software."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   739   C0011923:Imaging [Diagnostic Procedure]
   739   C0037585:Software [Intellectual Product,Manufactured Object]
   739   C0079595:Imaging [Diagnostic Procedure]
   739   C0333052:Version [Functional Concept]
   739   C1415856:ID3 [Gene or Genome]
   739   C1513822:Network [Professional or Occupational Group]
   739   C1705739:Network [Manufactured Object]
   739   C1882071:Network [Conceptual Entity]
   739   C2607870:Version [Spatial Concept]
   706 E C1704254:Image [Intellectual Product]
   706 E C1704922:Image [Entity]
   706 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.64: Image reconstruction was performed using IDL Virtual Machine 6.0 software with Image 2D version. 

Phrase: "Image reconstruction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0020912:Image Reconstruction [Machine Activity]
           Reconstruction
   861   C0524865:Reconstruction [Therapeutic or Preventive Procedure]
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "IDL Virtual Machine 6.0 software with Image 2D version."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.65: To image apoptosis in purified islets, mice were treated with MLDS and SHDS as described above. 

Phrase: "To image apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in purified islets,"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "treated with MLDS"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0445550:Low dose [Quantitative Concept]
   790   C1708745:Low-Dose [Research Activity]
   753   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   753   C0178602:Dose [Quantitative Concept]
   753   C0205251:low [Qualitative Concept]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1299352:Low [Qualitative Concept]
   753   C1522326:Treated [Functional Concept]
   753   C1550472:low [Idea or Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "SHDS as described above."
Processing 00000000.tx.66: Pancreatic islets were isolated as described (40) and incubated in a 6-well plate with 5 g/ml annexin V Cy5.5 for 2 h at 37C. 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated as described"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "incubated in a 6-well plate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005971:Plate [Medical Device]
   753   C0205170:Well [Qualitative Concept]
   753   C1139930:plate [Medical Device]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C3146287:Well [Manufactured Object]
   753   C3537155:Plate [Manufactured Object]

Phrase: "with 5 g/ml annexin V Cy5.5"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   893   C0450380:5/5 [Quantitative Concept]
   818   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1300565:g/mL [Quantitative Concept]
   818   C1332095:ANNEXIN V [Gene or Genome]
   795   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   795   C0439084:>5 [Quantitative Concept]
   795   C0439267:g% [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]
   795   C0728893:+5 [Quantitative Concept]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.67: After incubation, islets were washed and the plate was placed in the imaging system. 

Phrase: "After incubation,"

Phrase: "islets"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "the plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "was"

Phrase: "placed in the imaging system."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C2697665:Imaging System [Manufactured Object]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   726   C0442504:Place [Spatial Concept]
   726 E C1704254:Image [Intellectual Product]
   726   C1704765:Place [Functional Concept]
   726 E C1704922:Image [Entity]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]
   726 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.68: Imaging in the Cy5.5 channel was performed as described above. 

Phrase: "Imaging in the Cy5.5 channel"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   753   C0011923:Imaging [Diagnostic Procedure]
   753   C0079595:Imaging [Diagnostic Procedure]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0439799:Channel [Spatial Concept]
   753   C1706095:Channel [Conceptual Entity]
   719 E C1704254:Image [Intellectual Product]
   719 E C1704922:Image [Entity]
   719 E C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "performed as described above."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.69: Histology and fluorescence microscopy. 

Phrase: "Histology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019638:Histology [Biomedical Occupation or Discipline]
  1000   C0205462:histology [Functional Concept]
  1000   C0344441:Histology [Laboratory Procedure]

Phrase: "and"

Phrase: "fluorescence microscopy."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.70: Immediately after the imaging sessions, pancreata were snap-frozen in liquid nitrogen and cut into serial sections. 

Phrase: "Immediately after the imaging sessions,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0205548:Immediately [Temporal Concept]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726   C1883016:Session [Event]
   726   C1883017:Session [Conceptual Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   966   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "snap-"

Phrase: "frozen in liquid nitrogen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]

Phrase: "and"

Phrase: "cut into serial sections."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0000925:Cut [Injury or Poisoning]
   770   C1883724:CUT [Phenomenon or Process]
Processing 00000000.tx.71: Islets were first identified using hematoxylin and eosin (H&E) staining. 

Phrase: "Islets"

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "hematoxylin and eosin (H&E) staining."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.72: One section adjacent to the H&E-stained section was processed with TUNEL (Apoptag apoptosis detection kit; Chemicon International, Temecula, CA). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "adjacent to the H&E-stained section"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "was"

Phrase: "processed with TUNEL"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   744   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0444930:End [Spatial Concept]
   744   C1167624:Labeling [Mental Process]
   744   C1522240:Processed [Phenomenon or Process]
   744   C1947902:Labeling [Manufactured Object]
   744   C2746065:End [Temporal Concept]
   744   C2827499:Labeling [Governmental or Regulatory Activity]
   739   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   711 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "(Apoptag apoptosis detection kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "; Chemicon International, Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1555271:Temecula [Population Group]

Phrase: "CA)."
Processing 00000000.tx.73: The other section adjacent to the H&E-stained section was used for identification of annexin V Cy5.5 accumulation. 

Phrase: "The"

Phrase: "other section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "adjacent to the H&E-stained section"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "was"

Phrase: "used for identification of annexin V Cy5.5 accumulation."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   764   C1332095:ANNEXIN V [Gene or Genome]
   745   C1524063:Use of [Functional Concept]
   742   C0020792:Identification [Mental Process]
   742   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205396:Identification [Qualitative Concept]
   742   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C1273517:used [Finding]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.74: Both sections were counterstained with the nuclear stain DAPI. 

Phrase: "Both sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "counterstained with the nuclear stain DAPI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   753   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   753   C0521447:Nuclear [Spatial Concept]
Processing 00000000.tx.75: Sections were then subjected to correlative fluorescence microscopy in the FITC (TUNEL staining) channel for apoptosis assessment and the Cy5.5 (annexin V Cy5.5 staining) channel for probe localization using a Nikon Eclipse 50i fluorescence microscope equipped with an appropriate filter set (Chroma Technology, Rockingham, VT). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to correlative fluorescence microscopy"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C1511524:Correlative [Research Activity]
   760   C1707520:Correlative [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "in the FITC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: "(TUNEL staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0487602:Staining [Laboratory Procedure]
   795   C1704680:Staining [Finding]

Phrase: ")"

Phrase: "channel for apoptosis assessment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0162638:Apoptosis [Cell Function]
   770   C0439799:Channel [Spatial Concept]
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]
   770   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "the Cy5.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(annexin V Cy5.5 staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0487602:Staining [Laboratory Procedure]
   804   C1704680:Staining [Finding]

Phrase: ")"

Phrase: "channel for probe localization"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0182400:Probe [Medical Device]
   770   C0439799:Channel [Spatial Concept]
   770   C0475264:Localisation [Functional Concept]
   770   C1704681:Probe [Gene or Genome]
   770   C1706095:Channel [Conceptual Entity]
   770   C1744691:localisation [Biologic Function]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Nikon Eclipse 50i fluorescence microscope"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0181839:Microscope [Medical Device]
   804   C1706379:Microscope [Medical Device]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "equipped with an appropriate filter set (Chroma Technology,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0036849:Set [Mental Process]
   744   C0039421:Technology [Occupation or Discipline]
   744   C0180860:Filter [Manufactured Object]
   744   C0581406:Filter [Medical Device]
   744   C1442518:Set [Functional Concept]
   744   C1522664:Filter [Intellectual Product]
   744   C1548787:Appropriate [Qualitative Concept]
   744   C1704449:Filter [Conceptual Entity]
   744   C1704684:Filter [Medical Device]
   744   C1705195:Set [Conceptual Entity]
   744   C1875155:FILTER [Medical Device]

Phrase: "Rockingham,"

Phrase: "VT"

Phrase: ")."
Processing 00000000.tx.76: Images were acquired using a charged-coupled device camera with near-infrared sensitivity (SPOT 7.4 Slider RTKE; Diagnostic Instruments, Sterling Heights, MI) and analyzed using SPOT 4.0 advanced version software (Diagnostic Instruments, Sterling Heights, MI). 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a charged-coupled device camera with near-infrared sensitivity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0179533:Camera, device [Medical Device]
           Camera
   764   C1706254:Device Camera [Medical Device]
           CAMERA
   742   C1654607:Camera [Eukaryote]

Phrase: "(SPOT 7.4 Slider RTKE"

Phrase: "; Diagnostic Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Sterling Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "MI)"

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SPOT 4.0 advanced version software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Diagnostic Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Sterling Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "MI)."
Processing 00000000.tx.77: Statistical analysis of apoptotic rates was based on a total of 1,000 cells. 

Phrase: "Statistical analysis of apoptotic rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0871424:statistical analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "based on a total of 1,000 cells."
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   767   C1441375:Cells.total [Cell]
   744   C0007634:Cells [Cell]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C3282337:Cells [Cell]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1880279:Base [Biomedical or Dental Material]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.78: Results were analyzed by Students t test and represented as means  SE.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "analyzed by Students t test"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:Students [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   726 E C1551041:student [Idea or Concept]
   726 E C1552573:student [Intellectual Product]

Phrase: "and"

Phrase: "represented as means  SE."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737   C1882932:Represent [Activity]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.79: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  We tested the capacity of a Cy5.5-conjugated annexin V probe to detect apoptotic -cells in the pancreata of diabetic mice. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the capacity of a Cy5.5-conjugated annexin V"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1516240:Capacity [Quantitative Concept]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "apoptotic -cells in the pancreata of diabetic mice."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.80: We used four different mouse models: the MLDS model of type 1 diabetes, characterized by -cell apoptosis; 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "four different mouse models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "the MLDS model of type 1 diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3161035:Model [Intellectual Product]

Phrase: "characterized by -cell apoptosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0162638:Apoptosis [Cell Function]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1880022:Characterized [Activity]
   770   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.81: the SHDS model, associated with high levels of cell death (4); 

Phrase: "the SHDS model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "associated with high levels of cell death"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   778   C0007587:Cell Death [Cell Function]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0699040:cell associated [Cell Component]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C0205250:High [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1299351:High [Qualitative Concept]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2700149:HIGH [Intellectual Product]
   714 E C0456079:Level [Classification]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(4"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.82: the NOD mouse model, in which symptoms develop in an age-dependent manner; 

Phrase: "the NOD mouse model,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Model [Intellectual Product]
   756   C0085243:Non-Obese Diabetic Mouse [Mammal]

Phrase: "in which symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683368:symptoms [Functional Concept]
  1000   C1457887:Symptoms [Sign or Symptom]

Phrase: "develop in an age-dependent manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001779:Age [Organism Attribute]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: ";"
Processing 00000000.tx.83: and the BKS. 

Phrase: "and"

Phrase: "the BKS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1842851:BKS [Gene or Genome]
Processing 00000000.tx.84: Cg-m+/+Leprdb/J (db/db) model of type 2 diabetes, distinguished by loss of pancreatic -cells. 

Phrase: "Cg-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]

Phrase: "m+/+"

Phrase: "Leprdb/J (db/db) model of type 2 diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]

Phrase: "distinguished by loss of pancreatic -cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C1517945:Loss [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.85: MLDS and SHDS models of type 1 diabetes. 

Phrase: "MLDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "SHDS"

Phrase: "models of type 1 diabetes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.86: The specificity of annexin V Cy5.5 for apoptotic -cells was evaluated by flow cytometry of dispersed islet cells with dual channels for annexin V Cy5.5 (FL4) and anti-insulin FITC (FL1). 

Phrase: "The specificity of annexin V Cy5.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "for apoptotic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "evaluated by flow cytometry of dispersed islet cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   770   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   744   C0007634:Cells [Cell]
   744   C0220825:Evaluated [Functional Concept]
   744   C0332624:Dispersed [Spatial Concept]
   744   C0806140:Flow [Natural Phenomenon or Process]
   744   C0814048:Cytometry [Laboratory Procedure]
   744   C3282337:Cells [Cell]
   737 E C1522529:Islet Cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "with dual channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "for annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(FL4"

Phrase: ")"

Phrase: "and"

Phrase: "anti-insulin FITC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0124209:Isothiocyanate [Organic Chemical]
   812   C0206359:isothiocyanate [Organic Chemical]

Phrase: "(FL1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2751665:FL1 [Finding]

Phrase: ")."
Processing 00000000.tx.87: Analysis was performed after gating on cells negative for the vital dye 7-AAD. 

Phrase: "Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed after gating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "on cells negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: "for the vital dye 7-AAD."
Processing 00000000.tx.88: As expected, a small fraction of cells derived from age-matched untreated BALB/c mice stained for annexin V. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "a small fraction of cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   781   C0805525:Cell Fraction [Cell Component]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "derived from age-matched untreated BALB/c mice"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0025919:Mice, BALB C [Mammal]
           BALB/C
   744   C0001779:Age [Organism Attribute]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0150103:matched [Research Activity]
   744   C0332155:untreated [Finding]
   744   C1441547:Derived [Qualitative Concept]
   744   C1708943:Matched [Qualitative Concept]
   744   C3245521:derived [Idea or Concept]

Phrase: "stained for annexin V."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332095:ANNEXIN V [Gene or Genome]
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.89: In agreement with previous reports, the level of apoptosis in islet cells from MLDS-treated mice was more than twofold higher than controls (41,42), and cell death in isolated islet cells from SHDS-treated mice approached 40% compared with 0.75% in controls (4) (Fig. 1A). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with previous reports,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "the level of apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "in islet cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "from MLDS-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "more than twofold higher"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205172:More [Functional Concept]
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "than controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(41,"

Phrase: "42"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cell death in isolated islet cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0007587:Cell Death [Cell Function]
           cells death
   783   C0022131:cell islet [Body Part, Organ, or Organ Component]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   748   C0007616:Cell Isolation [Laboratory Procedure]

Phrase: "from SHDS-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "approached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449445:Approach [Spatial Concept]

Phrase: "40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "compared with 0.75%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(4"

Phrase: ")"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.90: It is important to note that the apoptotic rates reported by this method may be skewed because of the severe impairment of islet yield as a result of diabetes induction. 

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the apoptotic rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "reported by this method"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1709908:Reported By [Group]
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C0871511:METHOD [Intellectual Product]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "skewed because of the severe impairment of islet yield"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205082:Severe [Qualitative Concept]
   742   C0684336:Impairment [Pathologic Function]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of diabetes induction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.91: This is particularly true for the SHDS model, in which our analysis was based on a comparatively low number of cells. 

Phrase: "This"

Phrase: "is"

Phrase: "particularly true for the SHDS model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205238:True [Qualitative Concept]

Phrase: "in which"

Phrase: "our analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "based on a comparatively low number of cells."
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   750   C0007584:Cell Number [Laboratory Procedure]
   750   C2981742:Base Number [Conceptual Entity]
   744   C0007634:Cells [Cell]
   744   C0205251:low [Qualitative Concept]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1299352:Low [Qualitative Concept]
   744   C1527178:Based [Functional Concept]
   744   C1550472:low [Idea or Concept]
   744   C1705938:Based [Idea or Concept]
   744   C3282337:Cells [Cell]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1880279:Base [Biomedical or Dental Material]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.92: View larger version (82K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(82K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.93: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.94: In vitro apoptosis detection using annexin V Cy5.5 in MLDS- and SHDS-treated BALB/c mice. 

Phrase: "In vitro apoptosis detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "annexin V Cy5.5 in MLDS-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   764   C0445550:Low dose [Quantitative Concept]
   764   C1332095:ANNEXIN V [Gene or Genome]
   764   C1708745:Low-Dose [Research Activity]
   742   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   742   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0178602:Dose [Quantitative Concept]
   742   C0205251:low [Qualitative Concept]
   742   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0439064:Multiple [Quantitative Concept]
   742   C0869039:Dose [Quantitative Concept]
   742   C1114758:Dose # [Clinical Attribute]
   742   C1299352:Low [Qualitative Concept]
   742   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "SHDS-treated BALB/c mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0025919:Mice, BALB C [Mammal]
           BALB/C
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.95: A: Flow cytometry of cells derived from pancreatic islets of MLDS- and SHDS-treated mice and nontreated controls. 

Phrase: "A"

Phrase: ":"

Phrase: "Flow cytometry of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]

Phrase: "derived from pancreatic islets of MLDS-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   764   C0445550:Low dose [Quantitative Concept]
   764   C1708745:Low-Dose [Research Activity]
   742   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   742   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   742   C0178602:Dose [Quantitative Concept]
   742   C0205251:low [Qualitative Concept]
   742   C0439064:Multiple [Quantitative Concept]
   742   C0869039:Dose [Quantitative Concept]
   742   C1114758:Dose # [Clinical Attribute]
   742   C1299352:Low [Qualitative Concept]
   742   C1441547:Derived [Qualitative Concept]
   742   C1550472:low [Idea or Concept]
   742   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "SHDS-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "nontreated controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.96: A larger fraction of -cells (FL1+, insulin) derived from diabetic mice showed a shift in fluorescence in the FL4 (annexin V Cy5.5) channel compared with control mice. 

Phrase: "A larger fraction of -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(FL1+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2751665:FL1 [Finding]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "derived from diabetic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0241863:DIABETIC [Finding]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a shift in fluorescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333051:Shift [Functional Concept]
   770   C2347509:Shift [Phenomenon or Process]

Phrase: "in the FL4"

Phrase: "(annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "compared with control mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.97: B: Fluorescence imaging of islets isolated from diabetic and control mice and incubated in vitro with annexin V Cy5.5. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "imaging of islets"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0011923:Imaging [Diagnostic Procedure]
   790   C0079595:Imaging [Diagnostic Procedure]
   756 E C1704254:Image [Intellectual Product]
   756 E C1704922:Image [Entity]
   756 E C3542466:Image [Intellectual Product]

Phrase: "isolated from diabetic"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205409:Isolated [Functional Concept]
   790   C0241863:DIABETIC [Finding]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in vitro with annexin V Cy5.5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.98: Islets from diabetic mice showed higher fluorescence in the Cy5.5 channel.  

Phrase: "Islets from diabetic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   802   C1522528:Mouse Islets [Tissue]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "higher fluorescence in the Cy5.5 channel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
Processing 00000000.tx.99: The differential staining was confirmed by fluorescence imaging of STZ-treated versus nontreated isolated intact islets (Fig. 1B). 

Phrase: "The differential staining"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0443199:Differential [Qualitative Concept]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   861   C1705242:Differential [Qualitative Concept]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "confirmed by fluorescence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0016315:Fluorescence [Natural Phenomenon or Process]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]
   718 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "imaging of STZ-treated"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "versus"

Phrase: "nontreated isolated intact islets"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: Nontreated islets produced no signal in the Cy5.5 channel with a few signal-positive foci in islets from MLDS-treated mice. 

Phrase: "Nontreated islets"

Phrase: "produced"

Phrase: "no signal in the Cy5.5 channel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "with a few signal-positive foci"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0205234:Foci [Spatial Concept]
   779 E C1285542:focus [Functional Concept]

Phrase: "in islets"

Phrase: "from MLDS-treated mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.101: A larger fraction of islets from SHDS-treated mice stained for annexin V. 

Phrase: "A larger fraction of islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "from SHDS-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "stained for annexin V."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332095:ANNEXIN V [Gene or Genome]
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.102: To investigate the in vivo accumulation of annexin V Cy5.5, pancreata of MLDS- and SHDS-treated mice were removed 6 h after intravenous administration of the probe and imaged ex vivo. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the in vivo accumulation of annexin V Cy5.5,"

Phrase: "pancreata of MLDS-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   719   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "SHDS-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "6 h after intravenous administration of the probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0444953:H 6 [Intellectual Product]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "imaged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "ex vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348480:ex vivo [Functional Concept]
   861   C1515655:vivo [Spatial Concept]
Processing 00000000.tx.103: There were distinct foci of NIRF signal due to probe binding in the pancreata of STZ-induced diabetic mice. 

Phrase: "There"

Phrase: "were"

Phrase: "distinct foci of NIRF signal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205234:Foci [Spatial Concept]
   726 E C1285542:focus [Functional Concept]

Phrase: "due to probe binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "in the pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   966   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "of STZ-induced diabetic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.104: By comparison, the signal associated with pancreata from nontreated animals was at or near background levels (Fig. 2A). 

Phrase: "By comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "the signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "associated with pancreata"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   756 E C0750490:Associate [Idea or Concept]
   756   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "from nontreated animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "was at"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0043194:WAS [Disease or Syndrome]
   833   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1421478:WAS [Gene or Genome]

Phrase: "or"

Phrase: "near background levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   827   C1706907:Background [Conceptual Entity]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.105: Selective accumulation of our probe in islet regions containing apoptotic cells was confirmed by TUNEL assay on frozen sections: considering that the two methods define different stages of apoptosis, regions of annexin localization within islets correlated spatially with apoptotic events detected by TUNEL assay. 

Phrase: "Selective accumulation of our probe"

Phrase: "in islet regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "confirmed by TUNEL assay"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   764   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   742   C0005507:Assay [Laboratory Procedure]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0243073:assay [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0750484:Confirmed [Idea or Concept]
   742   C1167624:Labeling [Mental Process]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1947902:Labeling [Manufactured Object]
   742   C2746065:End [Temporal Concept]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   734   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   708 E C0181496:Label [Manufactured Object]
   708 E C1456348:Confirm [Qualitative Concept]

Phrase: "on frozen sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0016741:Frozen Sections [Tissue]
   966 E C0085188:Frozen Section [Laboratory Procedure]
   861   C0016701:Frozen [Natural Phenomenon or Process]
   861   C0677542:Frozen [Functional Concept]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: ":"

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "that"

Phrase: "the two methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "define"

Phrase: "different stages of apoptosis,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1306673:Stages [Qualitative Concept]
   737 E C0205390:Stage [Temporal Concept]
   737 E C1300072:Stage [Clinical Attribute]

Phrase: "regions of annexin localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "within islets"

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "spatially with apoptotic events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441471:Events [Event]
   770   C1516044:Apoptotic [Qualitative Concept]
   770   C3541888:Events [Classification]

Phrase: "detected by TUNEL assay."
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   742   C0005507:Assay [Laboratory Procedure]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0243073:assay [Qualitative Concept]
   742   C0442726:Detected [Finding]
   742   C0444930:End [Spatial Concept]
   742   C1167624:Labeling [Mental Process]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1947902:Labeling [Manufactured Object]
   742   C2746065:End [Temporal Concept]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   734   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   708 E C0181496:Label [Manufactured Object]
Processing 00000000.tx.106: As expected, in the MLDS model, only a few cells within islets bound annexin V and stained for TUNEL (2.3  0.2 and 1.6  0.2%, respectively), but in the SHDS model, a significant proportion of cells accumulated the probe and were TUNEL positive (26.3  0.8 and 17.5  0.63%, respectively, P < 0.05; Figs. 2B and Table 1). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "in the MLDS model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few cells within islets"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   797   C0022131:cells islets [Body Part, Organ, or Organ Component]
   764 E C1522529:Islet Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "stained for TUNEL"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   760   C0200687:Terminal transferase stain [Laboratory Procedure]
   744   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0444930:End [Spatial Concept]
   744   C1167624:Labeling [Mental Process]
   744   C1947902:Labeling [Manufactured Object]
   744   C2746065:End [Temporal Concept]
   744   C2827499:Labeling [Governmental or Regulatory Activity]
   744   C2986582:Stained [Qualitative Concept]
   739   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(2.3  0.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1519042:2-3 [Research Activity]
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "1.6  0.2%,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0580272:1/2 [Intellectual Product]
   902   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "but in the SHDS model,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C3161035:Model [Intellectual Product]

Phrase: "a significant proportion of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "accumulated"

Phrase: "the probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "were"

Phrase: "TUNEL positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0439178:% Positive [Quantitative Concept]
   795   C1446409:Positive [Qualitative Concept]
   795   C1514241:Positive [Finding]
   795   C2825490:Positive [Qualitative Concept]

Phrase: "(26.3  0.8"

Phrase: "and"

Phrase: "17.5  0.63%,"

Phrase: "respectively,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Figs. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.107: View larger version (82K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(82K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.108: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.109: Ex vivo apoptosis detection using annexin V Cy5.5 in MLDS- and SHDS-treated BALB/c mice. 

Phrase: "Ex vivo apoptosis detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "annexin V Cy5.5 in MLDS-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   764   C0445550:Low dose [Quantitative Concept]
   764   C1332095:ANNEXIN V [Gene or Genome]
   764   C1708745:Low-Dose [Research Activity]
   742   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   742   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0178602:Dose [Quantitative Concept]
   742   C0205251:low [Qualitative Concept]
   742   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0439064:Multiple [Quantitative Concept]
   742   C0869039:Dose [Quantitative Concept]
   742   C1114758:Dose # [Clinical Attribute]
   742   C1299352:Low [Qualitative Concept]
   742   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "SHDS-treated BALB/c mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0025919:Mice, BALB C [Mammal]
           BALB/C
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.110: A: Ex vivo NIRF imaging of pancreata derived from MLDS- and SHDS-treated mice. 

Phrase: "A"

Phrase: ":"

Phrase: "Ex vivo NIRF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1416389:NIRF [Gene or Genome]
   827   C1421349:NIRF [Gene or Genome]
   734   C2348480:ex vivo [Functional Concept]

Phrase: "imaging of pancreata"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   841   C0920628:pancreas imaging [Diagnostic Procedure]
   790   C0011923:Imaging [Diagnostic Procedure]
   790   C0079595:Imaging [Diagnostic Procedure]
   756   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   756   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   756 E C1704254:Image [Intellectual Product]
   756 E C1704922:Image [Entity]
   756 E C3542466:Image [Intellectual Product]

Phrase: "derived from MLDS-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0445550:Low dose [Quantitative Concept]
   790   C1708745:Low-Dose [Research Activity]
   753   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   753   C0178602:Dose [Quantitative Concept]
   753   C0205251:low [Qualitative Concept]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1299352:Low [Qualitative Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C1550472:low [Idea or Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "SHDS-treated mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.111: Pancreata derived from nontreated animals were used as controls. 

Phrase: "Pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   966   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "derived from nontreated animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003062:Animals [Animal]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.112: Strongly fluorescing foci were visible in treated pancreata and not in controls. 

Phrase: "Strongly fluorescing foci"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205234:Foci [Spatial Concept]
   793 E C1285542:focus [Functional Concept]

Phrase: "were"

Phrase: "visible in treated pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   779   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "not in controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1518422:Not [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.113: Results are representative of three animals. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of three animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.114: B: Fluorescence microscopy of adjacent pancreatic tissue sections derived from MLDS- and SHDS-treated mice. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Fluorescence microscopy of adjacent pancreatic tissue sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0026018:Microscopy [Laboratory Procedure]

Phrase: "derived from MLDS-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0445550:Low dose [Quantitative Concept]
   790   C1708745:Low-Dose [Research Activity]
   753   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   753   C0178602:Dose [Quantitative Concept]
   753   C0205251:low [Qualitative Concept]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1299352:Low [Qualitative Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C1550472:low [Idea or Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "SHDS-treated mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.115: Pancreatic islets were identified on H&E-stained sections. 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "identified on H&E-stained sections."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   845   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   757   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   748   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0205396:Identified [Qualitative Concept]
   748   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]
Processing 00000000.tx.116: One adjacent section was observed under the Cy5.5 filter to evaluate annexin V accumulation. 

Phrase: "One adjacent section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "observed under the Cy5.5 filter to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   748   C0180860:Filter [Manufactured Object]
   748   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0581406:Filter [Medical Device]
   748   C1441672:Observed [Functional Concept]
   748   C1522664:Filter [Intellectual Product]
   748   C1704449:Filter [Conceptual Entity]
   748   C1704684:Filter [Medical Device]
   748   C1875155:FILTER [Medical Device]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "annexin V accumulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332095:ANNEXIN V [Gene or Genome]
Processing 00000000.tx.117: The other adjacent section was subjected to TUNEL staining (FITC channel). 

Phrase: "The"

Phrase: "other adjacent section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "subjected to TUNEL staining"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0444930:End [Spatial Concept]
   742   C0487602:Staining [Laboratory Procedure]
   742   C1167624:Labeling [Mental Process]
   742   C1704680:Staining [Finding]
   742   C1947902:Labeling [Manufactured Object]
   742   C2746065:End [Temporal Concept]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   734   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "(FITC channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.118: There was a good correlation between TUNEL and annexin V Cy5.5 staining. 

Phrase: "There"

Phrase: "was"

Phrase: "a good correlation between TUNEL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "annexin V Cy5.5 staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0487602:Staining [Laboratory Procedure]
   804   C1704680:Staining [Finding]
Processing 00000000.tx.119: Arrows point to cells staining with annexin V Cy5.5 and with TUNEL. 

Phrase: "Arrows point to cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "staining with annexin V Cy5.5"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and with TUNEL."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0444930:End [Spatial Concept]
   744   C1167624:Labeling [Mental Process]
   744   C1515981:And [Idea or Concept]
   744   C1947902:Labeling [Manufactured Object]
   744   C2746065:End [Temporal Concept]
   744   C2827499:Labeling [Governmental or Regulatory Activity]
   739   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
Processing 00000000.tx.120: Islets from SHDS-treated mice demonstrated greater staining in both channels compared with MLDS-treated mice.  

Phrase: "Islets from SHDS-treated mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   781   C1522528:Mouse Islets [Tissue]

Phrase: "demonstrated"

Phrase: "greater staining in both channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "compared with MLDS-treated mice."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   770   C0445550:Low dose [Quantitative Concept]
   770   C1708745:Low-Dose [Research Activity]
   767   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   744   C0178602:Dose [Quantitative Concept]
   744   C0205251:low [Qualitative Concept]
   744   C0439064:Multiple [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1299352:Low [Qualitative Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1550472:low [Idea or Concept]
   744   C1707455:Compared [Activity]
   711 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.121: View this table: [in this window] [in a new window]  TABLE 1 Apoptotic rates in pancreatic tissue sections from mouse models of diabetes, as determined by annexin V Cy5.5 and TUNEL staining  NOD model of type 1 diabetes. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Apoptotic rates in pancreatic tissue sections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]

Phrase: "from mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "models of diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C3161035:Model [Intellectual Product]

Phrase: "as"

Phrase: "determined by annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "TUNEL staining  NOD model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3161035:Model [Intellectual Product]

Phrase: "of type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.122: NOD mice ranging in age from 3 to 12 weeks were used to evaluate apoptosis at different stages during the progression of type 1 diabetes. 

Phrase: "NOD mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "ranging in age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001779:Age [Organism Attribute]
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "from 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 12 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "apoptosis at different stages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "during the progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "of type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.123: Average blood glucose levels in NOD mice of all ages were in the normal range and indicated that the animals were pre-diabetic (results not shown). 

Phrase: "Average blood glucose levels in NOD mice of all ages"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   775   C0428554:blood glucose levels [Laboratory or Test Result]
   756   C0005802:Blood Glucose [Carbohydrate]
   756   C0428548:glucose levels [Laboratory or Test Result]
   738   C0005767:Blood [Tissue]
   738   C0005768:blood [Body Substance]
   738   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C0229664:Blood [Body Substance]
   738   C0441889:Levels [Qualitative Concept]
   737   C1511225:Mouse Blood [Tissue]
   722 E C0337438:glucose level [Laboratory Procedure]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "were in the normal range"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0086715:Normal Range [Quantitative Concept]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1514721:Range [Quantitative Concept]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "pre-diabetic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0362046:pre-diabetic [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: Flow cytometry of islet cells isolated from 3-, 6-, 8-, and 12-week-old mice showed an age-dependent progressive increase in the percentage of annexin V+ cells (ranging from 0.67% at 3 weeks to 3.45% at 12 weeks of age) (Fig. 3A). 

Phrase: "Flow cytometry of islet cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0016263:Flow Cytometry [Laboratory Procedure]
   760   C0806140:Flow [Natural Phenomenon or Process]
   760   C0814048:Cytometry [Laboratory Procedure]

Phrase: "isolated from 3-,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "6-,"

Phrase: "8-,"

Phrase: "and"

Phrase: "12-week-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an age-dependent progressive increase in the percentage of annexin V+ cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0442805:Increase [Functional Concept]

Phrase: "(ranging from 0.67%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "at 3 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442462:3 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "to 3.45%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "at 12 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age) (Fig. 3A"

Phrase: ")."
Processing 00000000.tx.125: The majority of annexin V+ cells also stained for insulin, suggesting that the predominant number of apoptotic events represent -cells. 

Phrase: "The majority of annexin V+ cells also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680220:majority [Social Behavior]

Phrase: "stained for insulin,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the predominant number of apoptotic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "represent -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.126: Because infiltrating lymphocytes can be a contributing factor to the total population of apoptotic cells, we analyzed cells from 8-week-old NOD mice double stained with annexin V Cy5.5 and an anti-CD3 antibody. 

Phrase: "Because"

Phrase: "infiltrating lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]

Phrase: "can"

Phrase: "be"

Phrase: "a contributing factor to the total population of apoptotic cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   757   C0960756:factor A [Organic Chemical]
   739   C1521761:Factor [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "cells from 8-week-old NOD mice"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "stained with annexin V Cy5.5"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "an anti-CD3 antibody."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0879551:Anti-CD3 Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
           Anti CD3
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C3542405:CD3 [Laboratory Procedure]
Processing 00000000.tx.127: Only 1% of CD3+ cells stained for annexin V, whereas 3.34% of the population fell in the annexin V Cy5.5+, CD3 quadrant. 

Phrase: "Only 1% of CD3+ cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   797   C0882828:Cells.CD3 [Cell]
   760   C0007634:Cells [Cell]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   760   C3282337:Cells [Cell]
   760   C3542405:CD3 [Laboratory Procedure]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "stained for annexin V,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332095:ANNEXIN V [Gene or Genome]
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "whereas"

Phrase: "3.34% of the population"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0032659:Population [Quantitative Concept]
   760   C0439086:<3 [Quantitative Concept]
   760   C1257890:Population [Population Group]
   760   C2827736:3+ [Quantitative Concept]
   760   C2981702:3+ [Classification]

Phrase: "fell in the annexin V Cy5.5+,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   778   C1332095:ANNEXIN V [Gene or Genome]
   748   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   714   C0085639:Fall [Finding]
   714   C0238715:Fall [Temporal Concept]

Phrase: "CD3 quadrant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1631280:Quadrant [Spatial Concept]
Processing 00000000.tx.128: Because this fraction is approximately the same as that determined to be apoptotic and insulin positive, we conclude that the majority of apoptotic cells are -cells (Fig. 3B). 

Phrase: "Because"

Phrase: "this fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "approximately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332232:Approximately [Qualitative Concept]

Phrase: "the same as that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1278655:SAME AS [Classification]
   770   C0445247:Same [Qualitative Concept]

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "apoptotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1516044:Apoptotic [Qualitative Concept]
   928 E C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "insulin positive,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the majority of apoptotic cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "are -"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.129: We need to emphasize that our estimate of the percentage of apoptotic cells within each group is only relative and attempts to clarify a trend associated with age. 

Phrase: "We"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "emphasize"

Phrase: "that"

Phrase: "our estimate of the percentage of apoptotic cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0750572:Estimate [Quantitative Concept]

Phrase: "within each group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "only relative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "a trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521798:trend [Temporal Concept]

Phrase: "associated with age."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0001779:Age [Organism Attribute]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.130: The trend of age-dependent increase in apoptosis was apparent in each of three independent experiments. 

Phrase: "The trend of age-dependent increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521798:trend [Temporal Concept]

Phrase: "in apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "apparent in each of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.131: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.132: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.133: In vitro apoptosis detection using annexin V Cy5.5 in pre-diabetic NOD mice. 

Phrase: "In vitro apoptosis detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "annexin V Cy5.5 in pre-diabetic NOD mice."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C0085243:Nonobese Diabetic Mice [Mammal]
           Non-Obese Diabetic Mice
   760   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0362046:pre-diabetic [Disease or Syndrome]
   760   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   760   C1332095:ANNEXIN V [Gene or Genome]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0241863:DIABETIC [Finding]
   739   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0332152:Pre [Temporal Concept]
   739   C0740175:Pre [Qualitative Concept]
   739   C2257086:PRE [Genetic Function]
Processing 00000000.tx.134: A: Flow cytometry of cells derived from pancreatic islets of 3-, 6-, 8-, and 12-week-old NOD mice revealed a trend toward an increase in the detected levels of -cell (FL1 channel, insulin) apoptosis (FL4 channel, annexin V Cy5.5) between 3 and 12 weeks of age. 

Phrase: "A"

Phrase: ":"

Phrase: "Flow cytometry of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]

Phrase: "derived from pancreatic islets of 3-,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "6-,"

Phrase: "8-,"

Phrase: "and"

Phrase: "12-week-old NOD mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0085243:Non-Obese Diabetic Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0241863:DIABETIC [Finding]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a trend toward an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521798:trend [Temporal Concept]

Phrase: "in the detected levels of -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(FL1 channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(FL4 channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "between 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "12 weeks of age."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.135: B: Cells from 8-week-old NOD mice were stained with annexin V Cy5.5 and an anti-CD3 antibody to evaluate the contribution from lymphocytes to the apoptotic cell population. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Cells from 8-week-old NOD mice"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with annexin V Cy5.5"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "an anti-CD3 antibody to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0879551:Anti-CD3 Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
           Anti CD3
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C3542405:CD3 [Laboratory Procedure]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the contribution from lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "to the apoptotic cell population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.136: The proportion of CD3+ (FL1) cells that stained with annexin V Cy5.5 (FL4) was 0.94 or 22% of all apoptotic cells.  

Phrase: "The proportion of CD3+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709707:Proportion [Quantitative Concept]

Phrase: "(FL1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2751665:FL1 [Finding]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "stained with annexin V Cy5.5"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(FL4"

Phrase: ")"

Phrase: "was"

Phrase: "0.94"

Phrase: "or"

Phrase: "22% of all apoptotic cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1516044:Apoptotic [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.137: The accumulation of in vivodelivered annexin V Cy5.5 appeared to be selective, because muscle tissue from the same animals produced no signal in ex vivo NIRF images (Fig. 4A). 

Phrase: "The accumulation of"

Phrase: "in vivodelivered annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   840   C1332095:ANNEXIN V [Gene or Genome]
   804   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "selective,"

Phrase: "because"

Phrase: "muscle tissue from the same animals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0026845:Muscle tissue [Tissue]
           Muscle
   790   C2328219:Muscle tissue [Tissue]
   767   C0229982:Animal tissue [Tissue]
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]

Phrase: "produced"

Phrase: "no signal in ex vivo NIRF images"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.138: Pancreata from 8- and 12-week-old mice had distinct foci of NIRF signal, consistent with the hypothesis that staining was islet specific. 

Phrase: "Pancreata from 8-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   756   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "12-week-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "distinct foci of NIRF signal,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205234:Foci [Spatial Concept]
   726 E C1285542:focus [Functional Concept]

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "islet"

Phrase: "specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]
Processing 00000000.tx.139: Histological analysis of pancreatic tissue from 3-, 6-, 8-, and 12-week-old mice confirmed the differential accumulation of annexin V Cy5.5 (Fig. 4B). 

Phrase: "Histological analysis of pancreatic tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "from 3-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6-,"

Phrase: "8-,"

Phrase: "and"

Phrase: "12-week-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the differential accumulation of annexin V Cy5.5"

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.140: The fraction of nuclei (DAPI) associated with fluorescence in the near-infrared range (annexin V Cy5.5) clearly increased with age. 

Phrase: "The fraction of nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1264633:Fraction of [Quantitative Concept]
           Fraction
   770   C1554103:Fraction [Idea or Concept]

Phrase: "(DAPI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "associated with fluorescence"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0016315:Fluorescence [Natural Phenomenon or Process]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in the near-infrared range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]

Phrase: "(annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "clearly"

Phrase: "increased with age."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.141: No annexin V binding was observed in sections derived from 3- and 6-week-old mice, whereas in 8- and 12-week-old animals, 2.6  0.34 and 3.2  0.2% of nuclei were associated with probe staining (Table 1). 

Phrase: "No annexin V binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332095:ANNEXIN V [Gene or Genome]

Phrase: "was"

Phrase: "observed in sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1441672:Observed [Functional Concept]
   756   C0205155:Section [Spatial Concept]
   756   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   756   C1522472:Section [Substance]
   756   C1552923:Section [Quantitative Concept]
   756   C1705191:Section [Physical Object]

Phrase: "derived from 3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "6-week-old mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "whereas in 8-"

Phrase: "and"

Phrase: "12-week-old animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "2.6  0.34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3.2  0.2% of nuclei"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439086:<3 [Quantitative Concept]
   753   C2827736:3+ [Quantitative Concept]
   753   C2981702:3+ [Classification]
   719   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "associated with probe staining"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0182400:Probe [Medical Device]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.142: TUNEL analysis of the consecutive slice produced a signal associated with apoptotic events, which could be due to dying -cells as well as infiltrating lymphocytes. 

Phrase: "TUNEL analysis of the consecutive slice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]

Phrase: "produced"

Phrase: "a signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "associated with apoptotic events,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0441471:Events [Event]
   770   C1516044:Apoptotic [Qualitative Concept]
   770   C3541888:Events [Classification]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "which"

Phrase: "could"

Phrase: "be due to dying -cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0007634:Cells [Cell]
   760   C0184532:dying [Organism Function]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "as well as"

Phrase: "infiltrating lymphocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.143: Apoptotic rates, as determined by TUNEL, were 0.6  0.1, 1.2  0.2, and 2.3  0.3% for 6-, 8-, and 12-week-old NOD mice, respectively, and reflected a trend similar to the one obtained with annexin V staining (Table 1). 

Phrase: "Apoptotic rates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "determined by TUNEL,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0444930:End [Spatial Concept]
   744   C1167624:Labeling [Mental Process]
   744   C1947902:Labeling [Manufactured Object]
   744   C2746065:End [Temporal Concept]
   744   C2827499:Labeling [Governmental or Regulatory Activity]
   739   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1333243:TERMINAL TRANSFERASE [Gene or Genome]

Phrase: "were"

Phrase: "0.6  0.1,"

Phrase: "1.2  0.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0580272:1/2 [Intellectual Product]
   861   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2.3  0.3% for 6-,"

Phrase: "8-,"

Phrase: "and"

Phrase: "12-week-old NOD mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0085243:Non-Obese Diabetic Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0241863:DIABETIC [Finding]

Phrase: "respectively,"

Phrase: "and"

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "a trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521798:trend [Temporal Concept]

Phrase: "similar to the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "obtained with annexin V staining"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1332095:ANNEXIN V [Gene or Genome]
   760   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1301820:Obtained [Functional Concept]
   760   C1704680:Staining [Finding]
   726 E C1706701:Obtain [Activity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.144: View larger version (69K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(69K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 4. 

Phrase: "4."
Processing 00000000.tx.146: Ex vivo apoptosis detection using annexin V Cy5.5 in pre-diabetic NOD mice. 

Phrase: "Ex vivo apoptosis detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "annexin V Cy5.5 in pre-diabetic NOD mice."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C0085243:Nonobese Diabetic Mice [Mammal]
           Non-Obese Diabetic Mice
   760   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0362046:pre-diabetic [Disease or Syndrome]
   760   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   760   C1332095:ANNEXIN V [Gene or Genome]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0241863:DIABETIC [Finding]
   739   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0332152:Pre [Temporal Concept]
   739   C0740175:Pre [Qualitative Concept]
   739   C2257086:PRE [Genetic Function]
Processing 00000000.tx.147: A: Ex vivo NIRF imaging of pancreata derived from 8- and 12-week-old NOD mice. 

Phrase: "A"

Phrase: ":"

Phrase: "Ex vivo NIRF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1416389:NIRF [Gene or Genome]
   827   C1421349:NIRF [Gene or Genome]
   734   C2348480:ex vivo [Functional Concept]

Phrase: "imaging of pancreata"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   841   C0920628:pancreas imaging [Diagnostic Procedure]
   790   C0011923:Imaging [Diagnostic Procedure]
   790   C0079595:Imaging [Diagnostic Procedure]
   756   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   756   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   756 E C1704254:Image [Intellectual Product]
   756 E C1704922:Image [Entity]
   756 E C3542466:Image [Intellectual Product]

Phrase: "derived from 8-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "12-week-old NOD mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0085243:Non-Obese Diabetic Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0241863:DIABETIC [Finding]
Processing 00000000.tx.148: Muscle tissue defined background signal. 

Phrase: "Muscle tissue"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0026845:Muscle tissue [Tissue]
           Muscle
  1000   C2328219:Muscle tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "background signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.149: Strongly fluorescing foci were visible in NOD mouse pancreata. 

Phrase: "Strongly fluorescing foci"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205234:Foci [Spatial Concept]
   793 E C1285542:focus [Functional Concept]

Phrase: "were"

Phrase: "visible in NOD mouse pancreata."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205379:Visible [Qualitative Concept]
Processing 00000000.tx.150: Results are representative of three animals. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of three animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.151: B: Fluorescence microscopy of adjacent pancreatic tissue sections derived from 3-, 6-, 8-, and 12-week-old NOD mice. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Fluorescence microscopy of adjacent pancreatic tissue sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0026018:Microscopy [Laboratory Procedure]

Phrase: "derived from 3-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "6-,"

Phrase: "8-,"

Phrase: "and"

Phrase: "12-week-old NOD mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0085243:Non-Obese Diabetic Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0241863:DIABETIC [Finding]
Processing 00000000.tx.152: Pancreatic islets were identified on H&E-stained sections. 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "identified on H&E-stained sections."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   845   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   757   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   748   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0205396:Identified [Qualitative Concept]
   748   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]
Processing 00000000.tx.153: One adjacent section was observed under the Cy5.5 filter to evaluate annexin V accumulation. 

Phrase: "One adjacent section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "observed under the Cy5.5 filter to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   748   C0180860:Filter [Manufactured Object]
   748   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0581406:Filter [Medical Device]
   748   C1441672:Observed [Functional Concept]
   748   C1522664:Filter [Intellectual Product]
   748   C1704449:Filter [Conceptual Entity]
   748   C1704684:Filter [Medical Device]
   748   C1875155:FILTER [Medical Device]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "annexin V accumulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332095:ANNEXIN V [Gene or Genome]
Processing 00000000.tx.154: The other adjacent section was subjected to TUNEL staining (FITC channel). 

Phrase: "The"

Phrase: "other adjacent section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "subjected to TUNEL staining"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0444930:End [Spatial Concept]
   742   C0487602:Staining [Laboratory Procedure]
   742   C1167624:Labeling [Mental Process]
   742   C1704680:Staining [Finding]
   742   C1947902:Labeling [Manufactured Object]
   742   C2746065:End [Temporal Concept]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   734   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "(FITC channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.155: There was a good correlation between TUNEL and annexin V Cy5.5 staining. 

Phrase: "There"

Phrase: "was"

Phrase: "a good correlation between TUNEL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "annexin V Cy5.5 staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0487602:Staining [Laboratory Procedure]
   804   C1704680:Staining [Finding]
Processing 00000000.tx.156: Arrows point to cells staining with annexin V Cy5.5 and with TUNEL.  

Phrase: "Arrows point to cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "staining with annexin V Cy5.5"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and with TUNEL."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0444930:End [Spatial Concept]
   744   C1167624:Labeling [Mental Process]
   744   C1515981:And [Idea or Concept]
   744   C1947902:Labeling [Manufactured Object]
   744   C2746065:End [Temporal Concept]
   744   C2827499:Labeling [Governmental or Regulatory Activity]
   739   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
Processing 00000000.tx.157: db/db model of type 2 diabetes. 

Phrase: "db/db model of type 2 diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.158: For this model, we used the BKS.Cg-m+/+Leprdb/J strain, in which the db/db mutation is placed on the highly diabetes-prone C57BLKS/J genetic background. 

Phrase: "For this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BKS.Cg-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "m+/+"

Phrase: "Leprdb/J strain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0080194:Strain [Injury or Poisoning]
   827   C0456178:strain [Intellectual Product]
   827   C1518614:Strain [Organism]
   827   C2987481:Strain [Mental Process]

Phrase: "in which"

Phrase: "the db/db mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "placed on the highly diabetes-prone C57BLKS/J genetic background."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C1511371:C57BLKS/J [Mammal]
   739   C0011847:Diabetes [Disease or Syndrome]
   739   C0011849:Diabetes [Disease or Syndrome]
   739   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   739   C0033422:Prone [Spatial Concept]
   739   C0205250:Highly [Qualitative Concept]
   739   C0314603:Genetic [Functional Concept]
   739   C1706907:Background [Conceptual Entity]
   713   C0032040:Birth Place [Finding]
   706   C0442504:Place [Spatial Concept]
   706   C1704765:Place [Functional Concept]
   706   C1882509:Place [Activity]
   706   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.159: The average blood glucose level in the 8-week-old db/db group was 317  36.9 mg/dl (n = 6) compared with 151  6.5 mg/dl in the controls (n = 3) (Fig. 5D). 

Phrase: "The average blood glucose level"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   923   C0428554:Blood glucose level [Laboratory or Test Result]
   861   C0005802:Blood Glucose [Carbohydrate]
   861   C0337438:glucose level [Laboratory Procedure]
   861   C0428548:Glucose level [Laboratory or Test Result]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0229664:Blood [Body Substance]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "in the 8-week-old db/db group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0441833:Group [Idea or Concept]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "317  36.9 mg/dl (n = 6"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0439269:mg dl [Quantitative Concept]
           mg%
   818   C0651569:9-MG [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C1960952:mg % [Quantitative Concept]
   795   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: "compared with 151  6.5 mg/dl"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0439269:mg dl [Quantitative Concept]
           mg%
   774 E C3463848:dl mg [Quantitative Concept]
   748   C1707455:Compared [Activity]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C3642216:/dL [Quantitative Concept]

Phrase: "in the controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.160: Flow cytometric analysis of islet cells isolated from these diabetic db/db and control mice demonstrated differential binding of the annexin V Cy5.5 probe (Fig. 5A). 

Phrase: "Flow cytometric analysis of islet cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "isolated from these diabetic db/db"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0205409:Isolated [Functional Concept]
   753   C0241863:DIABETIC [Finding]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "differential binding of the annexin V Cy5.5 probe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.161: Significantly more (7.24%) of insulin-positive, 7-AADnegative cells isolated from db/db mice had a signal in the FL4 (Cy5.5) channel compared with only 0.59% cells derived from control mice. 

Phrase: "Significantly more"

Phrase: "(7.24%"

Phrase: ")"

Phrase: "of insulin-positive,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "7-AADnegative cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "isolated from db/db mice"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "had"

Phrase: "a signal in the FL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "(Cy5.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "compared with only 0.59% cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0205171:Only [Quantitative Concept]
   753   C1707455:Compared [Activity]
   753   C1720467:Only [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "derived from control mice."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3245521:derived [Idea or Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.162: View larger version (66K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(66K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.164: Apoptosis detection using annexin V Cy5.5 in diabetic db/db mice. 

Phrase: "Apoptosis detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "annexin V Cy5.5 in diabetic db/db mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   764   C1332095:ANNEXIN V [Gene or Genome]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0241863:DIABETIC [Finding]
   742   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.165: A: Flow cytometry of cells derived from pancreatic islets of db/db and control mice. 

Phrase: "A"

Phrase: ":"

Phrase: "Flow cytometry of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]

Phrase: "derived from pancreatic islets of db/db"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C1441547:Derived [Qualitative Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "control mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.166: There was a significant difference in the percentage of -cells (FL1 channel, insulin) that stained with annexin V Cy5.5 (FL4 channel, annexin V Cy5.5) between diabetic and control mice. 

Phrase: "There"

Phrase: "was"

Phrase: "a significant difference in the percentage of -cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "(FL1 channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "that"

Phrase: "stained with annexin V Cy5.5"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(FL4 channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "between diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.167: B: Ex vivo NIRF imaging of pancreata derived from db/db and C57BLKS/J (control) mice. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Ex vivo NIRF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1416389:NIRF [Gene or Genome]
   827   C1421349:NIRF [Gene or Genome]
   734   C2348480:ex vivo [Functional Concept]

Phrase: "imaging of pancreata"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   841   C0920628:pancreas imaging [Diagnostic Procedure]
   790   C0011923:Imaging [Diagnostic Procedure]
   790   C0079595:Imaging [Diagnostic Procedure]
   756   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   756   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   756 E C1704254:Image [Intellectual Product]
   756 E C1704922:Image [Entity]
   756 E C3542466:Image [Intellectual Product]

Phrase: "derived from db/db"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "C57BLKS/J (control) mice."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   912   C1511371:C57BLKS/J Mouse [Mammal]
   886   C1511372:C57BLKS Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.168: Strong fluorescence was associated with db/db mouse pancreata. 

Phrase: "Strong fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "associated with db/db mouse pancreata."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   773   C1518865:Mouse Pancreas [Tissue]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   719   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   719 E C0750490:Associate [Idea or Concept]
   719   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.169: Results are representative of three animals. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of three animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.170: C: Fluorescence microscopy of pancreatic tissue sections derived from db/db and control mice. 

Phrase: "C"

Phrase: ":"

Phrase: "Fluorescence microscopy of pancreatic tissue sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0026018:Microscopy [Laboratory Procedure]

Phrase: "derived from db/db"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "control mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.171: Pancreatic islets were identified on H&E-stained sections. 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "identified on H&E-stained sections."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   845   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   757   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   748   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0205396:Identified [Qualitative Concept]
   748   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]
Processing 00000000.tx.172: One adjacent section was observed under the Cy5.5 filter to evaluate annexin V accumulation. 

Phrase: "One adjacent section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "observed under the Cy5.5 filter to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   748   C0180860:Filter [Manufactured Object]
   748   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0581406:Filter [Medical Device]
   748   C1441672:Observed [Functional Concept]
   748   C1522664:Filter [Intellectual Product]
   748   C1704449:Filter [Conceptual Entity]
   748   C1704684:Filter [Medical Device]
   748   C1875155:FILTER [Medical Device]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "annexin V accumulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332095:ANNEXIN V [Gene or Genome]
Processing 00000000.tx.173: The other adjacent section was subjected to TUNEL staining (FITC channel). 

Phrase: "The"

Phrase: "other adjacent section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "subjected to TUNEL staining"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0444930:End [Spatial Concept]
   742   C0487602:Staining [Laboratory Procedure]
   742   C1167624:Labeling [Mental Process]
   742   C1704680:Staining [Finding]
   742   C1947902:Labeling [Manufactured Object]
   742   C2746065:End [Temporal Concept]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   734   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "(FITC channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.174: There was a population of stained cells in db/db but not in control mice. 

Phrase: "There"

Phrase: "was"

Phrase: "a population of stained cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "in db/db"

Phrase: "but"

Phrase: "not in control mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1518422:Not [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.175: Arrows point to cells staining both with annexin V Cy5.5 and TUNEL. 

Phrase: "Arrows point to cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "both with annexin V Cy5.5"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0238767:Both [Spatial Concept]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "TUNEL."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]
Processing 00000000.tx.176: D: Average blood glucose levels in db/db and control mice. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Average blood glucose levels in db/db"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   814   C0428554:blood glucose levels [Laboratory or Test Result]
   778   C0005802:Blood Glucose [Carbohydrate]
   778   C0428548:glucose levels [Laboratory or Test Result]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0229664:Blood [Body Substance]
   748   C0441889:Levels [Qualitative Concept]
   745 E C0337438:glucose level [Laboratory Procedure]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "control mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.177: Blood glucose was significantly elevated in diabetic mice (P = 0.018).  

Phrase: "Blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "elevated in diabetic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0205250:Elevated [Qualitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "(P = 0.018"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450304:0.018" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.178: In vivoadministered annexin V Cy5.5 specifically accumulated in the pancreata of db/db mice, as evidenced by the significantly higher NIRF signal yielded by the tissue from db/db compared with control C57BLKS/J tissue (Fig. 5B). 

Phrase: "In vivoadministered annexin V Cy5.5 specifically"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   827   C1332095:ANNEXIN V [Gene or Genome]
   799   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "accumulated in the pancreata of db/db mice,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   734   C1518865:Mouse Pancreas [Tissue]
   711   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   711   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "evidenced by the significantly higher NIRF signal"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C1416389:NIRF [Gene or Genome]
   748   C1421349:NIRF [Gene or Genome]
   748   C1710082:Signal [Phenomenon or Process]
   714   C0205250:High [Qualitative Concept]
   714   C0332120:Evidence [Functional Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "yielded by the tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "from db/db"

Phrase: "compared with control C57BLKS/J tissue"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1511371:C57BLKS/J [Mammal]
   753   C0040300:Tissue [Tissue]
   753   C0243148:control [Qualitative Concept]
   753   C1547928:Tissue [Intellectual Product]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.179: Histological examination of pancreata from diabetic mice showed Cy5.5+ foci due to accumulation of the probe (Fig. 5C), with no Cy5.5 signal in sections derived from control pancreata. 

Phrase: "Histological examination of pancreata"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0019637:histologic examination [Laboratory Procedure]

Phrase: "from diabetic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "Cy5.5+ foci due to accumulation of the probe"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0205234:Foci [Spatial Concept]
   708 E C1285542:focus [Functional Concept]

Phrase: "(Fig. 5C"

Phrase: ")"

Phrase: ","

Phrase: "with no Cy5.5 signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1710082:Signal [Phenomenon or Process]
   734   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]

Phrase: "in sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "derived from control pancreata."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0243148:control [Qualitative Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3245521:derived [Idea or Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   737   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.180: TUNEL staining was consistent with the Cy5.5 staining. 

Phrase: "TUNEL staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0487602:Staining [Laboratory Procedure]
   795   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "consistent with the Cy5.5 staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.181: Relative apoptotic rates as determined by annexin V Cy5.5 and TUNEL were comparable (2.3  0.3 and 2.0  0.12%, respectively) (Table 1). 

Phrase: "Relative apoptotic rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "determined by annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   790   C1332095:ANNEXIN V [Gene or Genome]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "TUNEL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "were"

Phrase: "comparable"

Phrase: "(2.3  0.3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1519042:2-3 [Research Activity]
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "2.0  0.12%,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "respectively"

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.182: The higher levels of apoptosis detected in db/db versus control mice correlated with differences in blood glucose levels between the two groups.  

Phrase: "The higher levels of apoptosis"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "detected in db/db"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "versus"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "correlated with differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1707520:Correlated [Qualitative Concept]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "between the two groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.183: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Diabetes is a major health care issue that is reaching epidemic proportions. 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is"

Phrase: "a major health care"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0086388:Health Care [Health Care Activity]
   827   C0018684:Health [Idea or Concept]
   827   C1947933:Care [Activity]
   727 E C0031206:healthiness [Finding]

Phrase: "issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "epidemic proportions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709707:Proportion [Quantitative Concept]
   777 E C0205351:Proportional [Qualitative Concept]
Processing 00000000.tx.184: Currently, the clinical diagnosis of diabetes is based on measurement of glucose levels. 

Phrase: "Currently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "the clinical diagnosis of diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "is"

Phrase: "based on measurement of glucose levels."
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   790   C0428548:glucose levels [Laboratory or Test Result]
   783   C0337438:Glucose measurement [Laboratory Procedure]
       E   glucose level
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0242485:Measurement [Functional Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C1880279:Base [Biomedical or Dental Material]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.185: However, abnormal blood glucose levels are a relatively late marker of the disease. 

Phrase: "However,"

Phrase: "abnormal blood glucose levels"
Meta Candidates (Total=22; Excluded=11; Pruned=0; Remaining=11)
   923   C0428554:blood glucose levels [Laboratory or Test Result]
   923   C0522083:abnormal glucose levels [Finding]
   875   C0580546:Abnormal glucose [Finding]
   861   C0005802:Blood Glucose [Carbohydrate]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   819   C0741583:abnormal blood vessel [Finding]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0229664:Blood [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "are"

Phrase: "a relatively late marker of the disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1511983:Disease Marker [Idea or Concept]
   748   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.186: Being able to identify early events in the progression to diabetes as diagnostic markers could enhance the potential for successful therapeutic intervention and lead to better understanding of the natural history and the pathology of the disease. 

Phrase: "Being"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "identify"

Phrase: "early events in the progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441471:Events [Event]
   760   C3541888:Events [Classification]

Phrase: "to diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "as diagnostic markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1511876:Diagnostic Marker [Clinical Attribute]
   827   C0005516:Marker [Clinical Attribute]

Phrase: "could"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the potential for successful therapeutic intervention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "understanding of the natural history"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0175860:Natural History [Occupation or Discipline]
   760   C0019664:History [Occupation or Discipline]
   760   C0019665:history [Intellectual Product]
   760   C0162340:Understanding [Mental Process]
   760   C0205296:Natural [Functional Concept]
   760   C0262512:History, NOS [Organism Attribute]
   760   C0262926:History [Finding]
   760   C1705255:History [Conceptual Entity]
   760   C2004062:History [Finding]

Phrase: "and"

Phrase: "the pathology of the disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.187: In our study, an annexin V Cy5.5 probe was assessed for its potential to detect diabetes-associated -cell death in mouse models of type 1 and type 2 diabetes, both in vitro and ex vivo, as a first step in noninvasive imaging of dying -cells. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "an annexin V Cy5.5 probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0182400:Probe [Medical Device]
   804   C1704681:Probe [Gene or Genome]
   804   C2347609:Probe [Chemical Viewed Functionally]
   804   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "assessed for its potential to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1516048:Assessed [Activity]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "diabetes-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "associated -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "cell death in mouse"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "models of type 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0441729:Type 1 [Classification]
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
   770   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "ex vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348480:ex vivo [Functional Concept]
   861   C1515655:vivo [Spatial Concept]

Phrase: "as"

Phrase: "a first step in noninvasive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205303:Non-invasive [Functional Concept]
   812   C2986496:Noninvasive [Classification]

Phrase: "imaging of dying -cells."
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   802   C1537000:cell imaging [Diagnostic Procedure]
   770   C0007634:Cells [Cell]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0184532:dying [Organism Function]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704653:Cell [Medical Device]
   737 E C1704922:Image [Entity]
   737 E C1948049:Cell [Spatial Concept]
   737 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.188: However, our current concept of an expected low frequency of apoptosis over a fairly long time span increases the difficulty in measuring apoptosis in most models of diabetes. 

Phrase: "However,"

Phrase: "our current concept of an expected low frequency of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0178566:concept [Idea or Concept]

Phrase: "over a fairly long time span"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1711300:Span [Conceptual Entity]
   812   C2700613:Span [Quantitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the difficulty in measuring apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1299586:Difficulty [Finding]

Phrase: "in most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "models of diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C3161035:Model [Intellectual Product]
Processing 00000000.tx.189: The time points used for assessment of apoptosis in the MLDS and NOD models of type 1 diabetes were early in the progression to diabetes, as reported for both models: in the MLDS model immediately after 5 days of STZ treatment (1,41) and in 3- to 12-week-old NOD mice (3). 

Phrase: "The time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "used for assessment of apoptosis"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   781   C1524063:Use of [Functional Concept]
   760   C0162638:Apoptosis [Cell Function]
   760   C1261322:Assessment [Health Care Activity]
   760   C1273517:used [Finding]
   760   C1516048:Assessment [Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "in the MLDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "NOD models of type 1 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Models [Intellectual Product]

Phrase: "were"

Phrase: "early in the progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1279919:Early [Temporal Concept]

Phrase: "to diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "as"

Phrase: "reported for both models"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3161035:Models [Intellectual Product]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: ":"

Phrase: "in the MLDS model immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C3161035:Model [Intellectual Product]

Phrase: "after 5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of STZ treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "41"

Phrase: ")"

Phrase: "and in 3-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to 12-week-old NOD mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0085243:Non-Obese Diabetic Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0241863:DIABETIC [Finding]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.190: Whereas occasional intraislet lymphocytes were detected at 34 weeks of age (4347), extensive lymphocytic infiltration is usually seen by 8 weeks of age. 

Phrase: "Whereas"

Phrase: "occasional intraislet lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024264:Lymphocytes [Cell]

Phrase: "were"

Phrase: "detected at 34 weeks of age (4347"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0001779:Age [Organism Attribute]
   748   C0439230:weeks [Temporal Concept]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   714 E C0332174:/week [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "extensive lymphocytic infiltration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1262091:lymphocytic infiltration [Disease or Syndrome]
   827   C0024264:Lymphocytic [Cell]
   827   C0332448:Infiltration [Pathologic Function]
   827   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   827   C1523986:Infiltration [Functional Concept]
   827   C2939172:Lymphocytic [Qualitative Concept]

Phrase: "is"

Phrase: "usually"

Phrase: "seen by 8 weeks of age."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0205397:Seen [Qualitative Concept]
   753   C0439230:weeks [Temporal Concept]
   719 E C0042789:see [Organism Function]
   719 E C0332174:/week [Temporal Concept]
   719 E C1947903:See [Activity]
Processing 00000000.tx.191: As expected from previous studies, our analysis using this new probe found elevated -cell death in pancreata of STZ-induced diabetic mice (1,4,41,48) and increasing levels of apoptosis in NOD mice between 3 and 12 weeks of age. 

Phrase: "As"

Phrase: "expected from previous studies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205156:Previous [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1517001:Expected [Idea or Concept]
   770   C1552607:previous [Temporal Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "our analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this new probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "elevated -cell death in pancreata of STZ-induced diabetic mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007587:Cell Death [Cell Function]
   739   C0007634:Cell [Cell]
   739   C0011065:Death [Organism Function]
   739   C1269647:Cell [Cell]
   739   C1306577:Death, NOS [Finding]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4,"

Phrase: "41,"

Phrase: "48"

Phrase: ")"

Phrase: "and"

Phrase: "increasing levels of apoptosis"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in NOD mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "between 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "12 weeks of age."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.192: This latter finding is consistent with the observed differential priming of diabetogenic CD8+ T-cells in the pancreatic lymph nodes of NOD mice between 4 and 8 weeks of age (5) and parallels the trend described by OBrien et al. 

Phrase: "This latter finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with the observed differential priming of diabetogenic CD8+ T-cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the pancreatic lymph nodes"
Meta Candidates (Total=15; Excluded=9; Pruned=0; Remaining=6)
  1000   C0229783:Pancreatic lymph nodes [Body Part, Organ, or Organ Component]
           Pancreatic nodes
   966 E C1280901:Pancreatic lymph node [Body Part, Organ, or Organ Component]
   901   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   867 E C0440747:LYMPH NODE [Tissue]
   867 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   827   C0024202:Lymph [Body Substance]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0746922:nodes [Body Part, Organ, or Organ Component]
   793 E C1706163:Node [Conceptual Entity]
   793 E C2697524:Node [Conceptual Entity]
   793 E C2700445:Node [Plant]
   743 E C0443268:Nodal [Spatial Concept]
   743 E C1417752:NODAL [Gene or Genome]
   721 E C0449725:Nodality [Spatial Concept]

Phrase: "of NOD mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "between 4"

Phrase: "and"

Phrase: "8 weeks of age (5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "parallels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "the trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521798:trend [Temporal Concept]

Phrase: "described by OBrien et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.193: (3). 

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.194: In addition, we identified increased apoptosis in pancreata of diabetic db/db mice (49). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "increased apoptosis in pancreata of diabetic db/db mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162638:Apoptosis [Cell Function]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.195: Remarkably, in the latter model, apoptosis was detected in both endocrine and exocrine tissue. 

Phrase: "Remarkably,"

Phrase: "in the latter model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "detected in both endocrine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0014136:Endocrine [Body System]
   770   C0442726:Detected [Finding]
   770   C0521425:Endocrine [Functional Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "exocrine tissue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.196: This observation suggests the contribution from lymphocytic cell death to the total pool of apoptotic events, a possibility that, to our knowledge, has not been addressed systematically. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the contribution from lymphocytic cell death"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "to the total pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "of apoptotic events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "a possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "that,"

Phrase: "to our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "systematically."
Processing 00000000.tx.197: The detection of immunological markers and inflammatory mediators in type 2 diabetes (5052), however, has engendered speculations of immune cell involvement (53,54). 

Phrase: "The detection of immunological markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "inflammatory mediators in type 2 diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   753   C0333348:Inflammatory [Functional Concept]
   719 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(5052"

Phrase: ")"

Phrase: ","

Phrase: "however,"

Phrase: "has"

Phrase: "engendered speculations of immune cell involvement"

Phrase: "(53,"

Phrase: "54"

Phrase: ")."
Processing 00000000.tx.198: Apoptosis itself can induce an immune response (53,55), and it is certainly feasible that depending on the magnitude and duration of the initial pathology, secondary phenomena, including insulitis, may appear with different timing and severity. 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "itself"

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an immune response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "(53,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "certainly feasible"

Phrase: "that"

Phrase: "depending on the magnitude"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449286:magnitude [Quantitative Concept]
   770   C1704240:Magnitude [Quantitative Concept]
   737   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "duration of the initial pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "secondary phenomena,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomena [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "insulitis,"

Phrase: "may"

Phrase: "appear with different timing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449243:Timing [Temporal Concept]
   770   C0700364:APPEAR [Qualitative Concept]
   770   C1704250:Timing [Conceptual Entity]
   770   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "severity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439793:Severity [Qualitative Concept]
  1000   C2983285:Severity [Intellectual Product]
   928 E C0205082:Severe [Qualitative Concept]
Processing 00000000.tx.199: Generally, levels of apoptosis, as determined by FACS of isolated primary pancreatic -cells, were higher than the ones reported by ex vivo annexin V Cy5.5 staining. 

Phrase: "Generally,"

Phrase: "levels of apoptosis,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "determined by FACS of isolated primary pancreatic -cells,"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   797   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   756   C0007616:Cell Sorting [Laboratory Procedure]
           Cell Isolation
           cells isolation
   738   C0007634:Cell [Cell]
           Cells
   738   C0016315:Fluorescence [Natural Phenomenon or Process]
   738   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   738   C0205225:Primary [Qualitative Concept]
   738   C0205409:Isolated [Functional Concept]
   738   C0237886:Sorting [Mental Process]
   738   C0439631:Primary [Therapeutic or Preventive Procedure]
   738   C0700314:sorting [Cell Function]
   738   C1269647:Cell [Cell]
   738   C1548221:Isolated [Idea or Concept]
   738   C1704653:Cell [Medical Device]
   738   C1879547:Activated [Activity]
   738   C1947906:Sorting [Activity]
   738   C1948049:Cell [Spatial Concept]
   738   C3282337:Cells [Cell]
   704 E C1515877:Activate [Functional Concept]

Phrase: "were"

Phrase: "higher than the ones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "reported by ex vivo annexin V Cy5.5 staining."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   764   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   764   C1332095:ANNEXIN V [Gene or Genome]
   764   C1709908:Reported By [Group]
   764   C2348480:ex vivo [Functional Concept]
   742   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0487602:Staining [Laboratory Procedure]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C1515655:vivo [Spatial Concept]
   742   C1704680:Staining [Finding]
   742   C3496591:Reported [Clinical Attribute]
   708 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.200: This is possibly due to the somewhat damaging isolation procedure, which has likely resulted in overestimation of the percentage of dead or dying cells by FACS. 

Phrase: "This"

Phrase: "is"

Phrase: "possibly due to the somewhat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C2362652:Possibly [Qualitative Concept]
   760   C2984079:Somewhat [Intellectual Product]
   760   C3146286:Due [Idea or Concept]

Phrase: "damaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0010957:Damage [Injury or Poisoning]
   966   C1883709:Damage [Functional Concept]

Phrase: "isolation procedure,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0204727:Isolation procedure [Therapeutic or Preventive Procedure]
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "which"

Phrase: "has"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "resulted in overestimation of the percentage of dead"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0011065:Dead [Organism Function]
   744   C0439165:Percentage [Quantitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "or"

Phrase: "dying cells by FACS."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   822   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   757   C0007616:Cell Sorting [Laboratory Procedure]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.201: We validated the specificity of in vivoadministered annexin V Cy5.5 for apoptotic cells. 

Phrase: "We"

Phrase: "validated"

Phrase: "the specificity of"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0037791:Specificity [Quantitative Concept]
   790   C1511884:Specificity [Quantitative Concept]
   718 E C0205369:Specific [Qualitative Concept]
   718 E C1552740:specific [Intellectual Product]

Phrase: "in vivoadministered annexin V Cy5.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   840   C1332095:ANNEXIN V [Gene or Genome]
   804   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "for apoptotic cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.202: The feasibility of using labeled annexin V as an in vivo probe is well supported by previous research. 

Phrase: "The feasibility of"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "labeled annexin V as an in vivo probe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1332095:ANNEXIN V [Gene or Genome]
   744   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "supported by previous research."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0035176:research supported [Quantitative Concept]
   770   C0035168:research [Research Activity]
   770   C0205156:Previous [Temporal Concept]
   770   C0242481:Research [Research Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1552607:previous [Temporal Concept]
   737 E C0183683:Support [Medical Device]
Processing 00000000.tx.203: In humans, 99mTc-labeled annexin V has been used to detect apoptosis in the hearts of patients with acute myocardial infarction (34) as well as during acute cardiac rejection (56) and in an intracardiac tumor (57). 

Phrase: "In humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "99mTc-labeled annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "apoptosis in the hearts of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162638:Apoptosis [Cell Function]

Phrase: "with acute myocardial infarction"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0155626:Acute myocardial infarction [Disease or Syndrome]
  1000   C3541950:ACUTE MYOCARDIAL INFARCTION [Finding]
   901   C0027051:Myocardial Infarction [Disease or Syndrome]
   901   C0428953:MYOCARDIAL INFARCTION [Finding]
   901   C2926063:Myocardial infarction [Clinical Attribute]
   863   C0333548:Acute infarct [Pathologic Function]
   827   C0021308:Infarction [Pathologic Function]
   827   C0027061:Myocardial [Tissue]
   827   C0205178:acute [Temporal Concept]
   827   C1522564:Myocardial [Spatial Concept]
   755 E C0333541:Infarcted [Functional Concept]

Phrase: "(34"

Phrase: ")"

Phrase: "as well as during acute cardiac rejection"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C3273245:Acute Rejection [Finding]
   748   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   748   C0035015:Rejection [Social Behavior]
   748   C0205170:Well [Qualitative Concept]
   748   C0205178:acute [Temporal Concept]
   748   C1522601:Cardiac [Spatial Concept]
   748   C1548437:Rejection [Idea or Concept]
   748   C1882923:REJECTION [Phenomenon or Process]
   748   C2700401:Rejection [Activity]
   748   C3146287:Well [Manufactured Object]

Phrase: "(56"

Phrase: ")"

Phrase: "and in an intracardiac tumor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0027651:Tumor [Neoplastic Process]
   760   C0729936:Intracardiac [Body Space or Junction]
   760   C1515981:And [Idea or Concept]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.204: More recently, 99mTc-labeled annexin V was used in a quantitative tumor apoptosis imaging study using single-photon emission computed tomography in patients with head and neck carcinoma (35,36). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "99mTc-labeled annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "used in a quantitative tumor apoptosis imaging study"
Meta Candidates (Total=18; Excluded=6; Pruned=0; Remaining=12)
   770   C1881134:Imaging Study [Diagnostic Procedure]
   750   C0869040:study use [Research Activity]
   744   C0011923:Imaging [Diagnostic Procedure]
   744   C0027651:Tumor [Neoplastic Process]
   744   C0079595:Imaging [Diagnostic Procedure]
   744   C0162638:Apoptosis [Cell Function]
   744   C0392762:Quantitative [Quantitative Concept]
   744   C0557651:Study [Manufactured Object]
   744   C1273517:used [Finding]
   744   C1578706:Tumor [Intellectual Product]
   744   C2603343:Study [Research Activity]
   744   C3273930:Tumor [Finding]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1704254:Image [Intellectual Product]
   711 E C1704922:Image [Entity]
   711 E C1947944:Use [Intellectual Product]
   711 E C3542466:Image [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "single-photon emission computed tomography in patients"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C0040399:Tomography, Emission-Computed, Single-Photon [Diagnostic Procedure]
           Single Photon Emission Tomography
   814   C0040398:Tomography, Emission-Computed [Diagnostic Procedure]
   778   C0040405:computed tomography [Diagnostic Procedure]
           tomography
   778   C1552357:Computed Tomography [Professional or Occupational Group]
   748   C0037179:Single [Population Group]
   748   C0040395:tomography [Diagnostic Procedure]
   748   C0086805:Photon [Substance]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0233929:Emission [Body Substance]
   748   C1441526:Computed [Laboratory Procedure]
   748   C1880157:Computed [Activity]
   748   C2349995:Emission [Substance]

Phrase: "with head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: "and"

Phrase: "neck carcinoma"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1334927:Neck Carcinoma [Neoplastic Process]
   972 E C0302592:Cervical carcinoma [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]

Phrase: "(35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.205: Biodistribution and dosimetry measurements of various forms of 99mTc-labeled annexin V in humans point to the safety of this tracer and its suitability for use in a clinical setting (5860). 

Phrase: "Biodistribution"

Phrase: "and"

Phrase: "dosimetry measurements of various forms of 99mTc-labeled annexin V"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0242485:measurements [Functional Concept]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "point to the safety of this tracer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0036043:Safety [Human-caused Phenomenon or Process]
   748   C1522485:Tracer [Indicator, Reagent, or Diagnostic Aid]
   748   C1552961:Point [Quantitative Concept]
   748   C1705187:SAFETY [Research Activity]
   748   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "its suitability for use"

Phrase: "in a clinical setting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3176918:Clinical setting [Spatial Concept]
   861   C0542559:setting [Functional Concept]
   861   C1318139:{Setting} [Quantitative Concept]

Phrase: "(5860"

Phrase: ")."
Processing 00000000.tx.206: In rodents, 99mTc-labeled annexin V was tested as a marker of apoptosis in a murine model of immune arthritis (61) and autoimmune myocarditis (62) as well as of chemotherapy-induced apoptosis in breast cancer (63) and hepatoma xenograft models (64). 

Phrase: "In rodents,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodents [Mammal]

Phrase: "99mTc-labeled annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "tested as a marker of apoptosis"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0005516:Marker [Clinical Attribute]
   753   C0162638:Apoptosis [Cell Function]
   753   C0392366:tested [Intellectual Product]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]

Phrase: "in a murine model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of immune arthritis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "(61"

Phrase: ")"

Phrase: "and"

Phrase: "autoimmune myocarditis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027059:Myocarditis [Disease or Syndrome]
   861   C1962971:Myocarditis [Finding]

Phrase: "(62"

Phrase: ")"

Phrase: "as well as of chemotherapy-induced apoptosis in breast cancer"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   775   C0006142:Cancer of Breast [Neoplastic Process]
           Breast Cancer
   775   C0678222:Cancer of Breast [Neoplastic Process]
           Breast Cancer
   757   C0392920:Cancer chemotherapy [Therapeutic or Preventive Procedure]
           Chemotherapy
   757   C0804755:Chemotherapy Cancer [Clinical Attribute]
   739   C0006141:Breast [Body Part, Organ, or Organ Component]
   739   C0006826:Cancer [Neoplastic Process]
   739   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   739   C0013217:chemotherapy [Functional Concept]
   739   C0162638:Apoptosis [Cell Function]
   739   C0205170:Well [Qualitative Concept]
   739   C0205263:Induced [Functional Concept]
   739   C0998265:Cancer [Eukaryote]
   739   C1268990:Breast [Body Part, Organ, or Organ Component]
   739   C1306459:Cancer [Finding]
   739   C3146287:Well [Manufactured Object]
   710 E C0153661:thoracic cancer [Neoplastic Process]

Phrase: "(63"

Phrase: ")"

Phrase: "and"

Phrase: "hepatoma xenograft models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1520166:Xenograft Model [Experimental Model of Disease]
   827   C3161035:Models [Intellectual Product]

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.207: Annexin V labeled with the fluorophore Cy5.5 (Cy) has been used as a probe for imaging of tumor apoptosis using NIRF in nude mice (38,39). 

Phrase: "Annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "labeled with the fluorophore Cy5.5 (Cy)"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0598447:fluorophore [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "has"

Phrase: "been"

Phrase: "used as a probe"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0182400:Probe [Medical Device]
   770   C1273517:used [Finding]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for"

Phrase: "imaging of tumor apoptosis"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0162638:Apoptosis [Cell Function]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NIRF in nude mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1416389:NIRF [Gene or Genome]
   770   C1421349:NIRF [Gene or Genome]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.208: Consistent with our observations, no toxicity was observed at doses up to 2.5 mg/kg, which is the highest reported dose (38). 

Phrase: "Consistent with our observations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "no toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "was"

Phrase: "observed at doses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0178602:Doses [Quantitative Concept]
   790   C1441672:Observed [Functional Concept]
   756 E C0869039:Dose [Quantitative Concept]
   756 E C1114758:Dose # [Clinical Attribute]
   756 E C1428722:DOS [Gene or Genome]

Phrase: "up to 2.5 mg/kg,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0439272:mg kg [Quantitative Concept]
   812   C0022718:KG [Geographic Area]
   812   C0439209:kg [Quantitative Concept]
   812   C0439269:mg% [Quantitative Concept]
   812   C1960952:mg % [Quantitative Concept]
   812   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "the highest reported dose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0444956:High dose [Quantitative Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.209: In addition, the small size of annexin V (35 kDa) allows for its rapid renal clearance (39). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the small size of annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0748864:small size [Finding]
   753   C0456389:size [Spatial Concept]
   753   C0700321:Small [Quantitative Concept]

Phrase: "(35 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "allows for its rapid renal clearance"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0232813:Renal clearance [Organ or Tissue Function]
   790   C0699829:Renal Clearance [Diagnostic Procedure]
   753   C0022646:Renal [Body Part, Organ, or Organ Component]
   753   C0439831:Rapid [Qualitative Concept]
   753   C0449297:Clearance [Qualitative Concept]
   753   C0683607:allow [Social Behavior]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.210: We propose that this probe has potential as an in vivo imaging tool because of its accumulation in pancreata of diabetic mice after delivery through the circulation. 

Phrase: "We"

Phrase: "propose"

Phrase: "that"

Phrase: "this probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "has"

Phrase: "potential as an in vivo imaging tool"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: "because of its accumulation"

Phrase: "in pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   966   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "of diabetic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "after delivery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011209:Delivery [Therapeutic or Preventive Procedure]
  1000   C0559563:delivery [Finding]
  1000   C1705822:Delivery [Activity]

Phrase: "through the circulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]
Processing 00000000.tx.211: We were able to observe clusters of dying cells in excised pancreata in different diabetic animal models after intravenous injection of the probe. 

Phrase: "We"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "observe"

Phrase: "clusters of dying cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1179412:cell clusters [Body Part, Organ, or Organ Component]
   737   C1555715:Cluster [Idea or Concept]
   737   C1704332:Cluster [Quantitative Concept]

Phrase: "in excised pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   827   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "in different diabetic animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0599779:Models, Animal [Animal]
   812   C0003062:Animal [Animal]
   812   C3161035:Models [Intellectual Product]

Phrase: "after intravenous injection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021494:Intravenous injection [Functional Concept]
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0348016:Intravenous [Spatial Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "of the probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.212: This study was limited to ex vivo imaging, although advances in optical imaging technology that will be essential for progress toward noninvasive in vivo measurement are anticipated. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "to ex vivo imaging,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0011923:Imaging [Diagnostic Procedure]
   812   C0079595:Imaging [Diagnostic Procedure]
   779 E C1704254:Image [Intellectual Product]
   779 E C1704922:Image [Entity]
   779 E C3542466:Image [Intellectual Product]

Phrase: "although"

Phrase: "advances in optical imaging technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0725066:Advance [Medical Device]

Phrase: "that"

Phrase: "will"

Phrase: "be"

Phrase: "essential for progress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205224:Essential [Qualitative Concept]

Phrase: "toward noninvasive in vivo measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0242485:Measurement [Functional Concept]

Phrase: "are"

Phrase: "anticipated."
Processing 00000000.tx.213: Issues such as tissue scattering, limited depth penetration, low spatial resolution, and inadequate capacity for quantitative estimation of probe accumulation need to be addressed in order to use in vivo optical imaging to detect and characterize discrete events such as isolated clusters of apoptotic cells within an internal organ. 

Phrase: "Issues such as tissue scattering,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0033213:Issue [Finding]
   726   C1706387:Issue [Intellectual Product]

Phrase: "limited depth penetration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205321:Penetration [Functional Concept]

Phrase: "low spatial resolution,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514893:Resolution [Idea or Concept]
   827   C1706463:Resolution [Quantitative Concept]
   827   C2699488:Resolution [Conceptual Entity]

Phrase: "and"

Phrase: "inadequate capacity for quantitative estimation of probe accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1516240:Capacity [Quantitative Concept]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "addressed in order to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]
   737   C0376649:Address [Intellectual Product]
   737   C1442065:Address [Spatial Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "in vivo optical imaging to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   888   C1708481:In Vivo Imaging [Laboratory Procedure]
   840   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   804   C0011923:Imaging [Diagnostic Procedure]
   804   C0079595:Imaging [Diagnostic Procedure]
   771 E C1704254:Image [Intellectual Product]
   771 E C1704922:Image [Entity]
   771 E C3542466:Image [Intellectual Product]
   748   C0042789:Vision [Organism Function]
   748   C2707266:Vision [Clinical Attribute]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "and"

Phrase: "characterize"

Phrase: "discrete events such as isolated clusters of apoptotic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441471:Events [Event]
   742   C3541888:Events [Classification]

Phrase: "within an internal organ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:Organ [Body Part, Organ, or Organ Component]
Processing 00000000.tx.214: Despite these shortcomings, optical imaging has several attractive features such as the use of nonionizing low-energy radiation, high sensitivity with the possibility of detecting micrometer-sized objects, continuous data acquisition, and the development of potentially cost-effective equipment. 

Phrase: "Despite these shortcomings,"

Phrase: "optical imaging"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]

Phrase: "has"

Phrase: "several attractive features such as the use of nonionizing low-energy radiation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   703   C1521970:Feature [Qualitative Concept]
   703   C1706388:Feature [Conceptual Entity]
   703   C2346469:Feature [Qualitative Concept]
   703   C2348519:Feature [Qualitative Concept]

Phrase: "high sensitivity with the possibility of detecting micrometer-sized objects,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C1441604:High sensitivity [Laboratory Procedure]
   739   C0036667:Sensitivity [Quantitative Concept]
   739   C0205250:High [Qualitative Concept]
   739   C0312418:Sensitivity [Mental Process]
   739   C0427965:Sensitivity [Finding]
   739   C1299351:High [Qualitative Concept]
   739   C1511883:Sensitivity [Quantitative Concept]
   739   C1522640:Sensitivity [Qualitative Concept]
   739   C2346484:SENSITIVITY [Phenomenon or Process]
   739   C2349185:Sensitivity [Qualitative Concept]
   739   C2700149:HIGH [Intellectual Product]

Phrase: "continuous data acquisition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706701:Acquisition [Activity]

Phrase: "and"

Phrase: "the development of potentially cost-effective equipment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
Processing 00000000.tx.215: Fast and relatively easy imaging procedures make this modality attractive for potential clinical use. 

Phrase: "Fast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015663:Fast [Finding]
  1000   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "relatively easy imaging procedures"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0079595:Imaging Procedures [Diagnostic Procedure]
   844 E C0011923:Imaging procedure [Diagnostic Procedure]
   812   C0025664:procedures [Intellectual Product]
   812   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C2700391:procedures [Activity]
   779 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   779 E C3274430:PROCEDURE [Health Care Activity]
   779 E C3538935:Procedure [Idea or Concept]
   779 E C3539779:Procedure [Intellectual Product]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "this modality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0695347:Modality [Idea or Concept]
  1000   C1547664:Modality [Diagnostic Procedure]

Phrase: "attractive for potential clinical use."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346874:Attractive [Qualitative Concept]
Processing 00000000.tx.216: Recently, several technical advances in developing highly sensitive detection devices have led to the biological use of cooled charged-coupled device cameras capable of imaging very low levels of light emitted from internal body organs of rodents. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "several technical advances in developing highly sensitive detection devices"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0725066:Advance [Medical Device]

Phrase: "have"

Phrase: "led to the biological use of cooled"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   778   C1524063:Use of [Functional Concept]
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0042153:use [Functional Concept]
   748   C0205460:biological [Qualitative Concept]
   748   C0457083:Use [Functional Concept]
   748   C1708698:LED [Manufactured Object]
   748   C1947944:Use [Intellectual Product]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714   C1548792:Cool [Qualitative Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "charged-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706211:Charged [Organism Attribute]
   966 E C0007961:Charge [Quantitative Concept]

Phrase: "coupled device cameras"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C0179533:Camera, device [Medical Device]
           cameras
   884   C1706254:Device Camera [Medical Device]
       E   CAMERA
   793 E C1654607:Camera [Eukaryote]

Phrase: "capable of imaging very low levels of light"

Phrase: "emitted from internal body organs of rodents."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   793   C0229983:organ of body [Body Part, Organ, or Organ Component]
           body organs
   762 E C1280836:Body organ [Body Part, Organ, or Organ Component]
   748   C0035804:Rodents [Mammal]
   748   C0178784:organs [Body Part, Organ, or Organ Component]
   748   C0205102:Internal [Spatial Concept]
   748   C0242821:body [Human]
   748   C0460148:Body [Anatomical Structure]
   748   C1268086:Body [Anatomical Structure]
   748   C1553872:Internal [Intellectual Product]
   748   C1619620:Internal [Intellectual Product]
   714   C0162676:EMIT [Laboratory Procedure]
   714   C1623049:EMIT [Laboratory Procedure]
Processing 00000000.tx.217: At the near-infrared region between 700 and 900 nm, absorption by intrinsic photoactive biomolecules is low and allows light to penetrate into the tissue to a depth sufficient for applications in small animals (59). 

Phrase: "At the near-infrared region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "between 700"

Phrase: "and"

Phrase: "900 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "absorption by intrinsic photoactive biomolecules"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0000854:Absorption [Natural Phenomenon or Process]
   760   C0220777:absorption [Functional Concept]
   760   C2347023:Absorption [Phenomenon or Process]
   760   C2347080:Absorption [Phenomenon or Process]
   760   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   760   C2825050:Absorption [Phenomenon or Process]

Phrase: "is"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "light to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "penetrate into the tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0040300:Tissue [Tissue]
   770   C0205321:penetrate [Functional Concept]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "to a depth"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205125:Depth [Spatial Concept]
   928 E C1422002:DEEPEST [Gene or Genome]

Phrase: "sufficient for applications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205410:Sufficient [Qualitative Concept]

Phrase: "in small animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.218: Therefore, imaging in the near-infrared region has the advantage of minimizing tissue autofluorescence and dramatically improving the target-to-background ratio (60). 

Phrase: "Therefore,"

Phrase: "imaging in the near-infrared region"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0011923:Imaging [Diagnostic Procedure]
   753   C0017446:Region [Geographic Area]
   753   C0079595:Imaging [Diagnostic Procedure]
   753   C0205147:Region [Spatial Concept]
   753   C1532326:Infrared [Qualitative Concept]
   719 E C1704254:Image [Intellectual Product]
   719 E C1704922:Image [Entity]
   719 E C3542466:Image [Intellectual Product]

Phrase: "has"

Phrase: "the advantage of minimizing tissue autofluorescence"

Phrase: "and"

Phrase: "dramatically"

Phrase: "improving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1272745:Improving [Qualitative Concept]

Phrase: "the target-to-background ratio"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1521840:Target [Functional Concept]
   812   C1547037:Ratio [Intellectual Product]
   812   C1706907:Background [Conceptual Entity]
   812   C2986546:TARGET [Diagnostic Procedure]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.219: Fluorescence imaging can be carried out at different resolutions and depth penetrations. 

Phrase: "Fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at different resolutions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C1705242:Different [Qualitative Concept]
   737   C1514893:Resolution [Idea or Concept]
   737   C1706463:Resolution [Quantitative Concept]
   737   C2699488:Resolution [Conceptual Entity]

Phrase: "and"

Phrase: "depth penetrations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205321:Penetration [Functional Concept]
Processing 00000000.tx.220: For example, some progress in resolving the above-mentioned problems has already been made by the application of fluorescence-mediated tomography, which delivers tomographic reconstruction of the image by mathematical modeling of diffusion and scattering and has achieved resolution of 12 mm and nanomolar sensitivity (65). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "some progress in resolving"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1272688:progress [Functional Concept]
   770   C1280477:Progress [Functional Concept]

Phrase: "the above-mentioned problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1546466:Problems [Idea or Concept]
   793 E C0033213:Problem [Finding]

Phrase: "has"

Phrase: "already"

Phrase: "been"

Phrase: "made by the application of fluorescence-mediated tomography,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0016315:Fluorescence [Natural Phenomenon or Process]
   744   C0040395:tomography [Diagnostic Procedure]
   744   C0040405:tomography [Diagnostic Procedure]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0185125:Application [Health Care Activity]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C3539080:APPLICATION [Quantitative Concept]
   711   C1881534:Make [Functional Concept]

Phrase: "which"

Phrase: "delivers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "tomographic reconstruction of the image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0020912:Image Reconstruction [Machine Activity]
           Reconstruction
   760   C0524865:Reconstruction [Therapeutic or Preventive Procedure]

Phrase: "by mathematical modeling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0876936:mathematical modeling [Intellectual Product]
   861   C0870071:Modeling [Intellectual Product,Research Activity]

Phrase: "of diffusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012222:Diffusion [Natural Phenomenon or Process]
  1000   C1696141:Diffusion [Functional Concept]

Phrase: "and"

Phrase: "scattering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439742:Scattering [Spatial Concept]

Phrase: "and"

Phrase: "has"

Phrase: "achieved resolution of 12 mm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514893:Resolution [Idea or Concept]
   760   C1706463:Resolution [Quantitative Concept]
   760   C2699488:Resolution [Conceptual Entity]

Phrase: "and"

Phrase: "nanomolar sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.221: Alternatively, the application of a recently described multimodality strategy (66), combining the sensitivity of optical imaging methods with a modality delivering higher spatial resolution and tomographic capabilities, would represent a step toward in vivo use of similar probes. 

Phrase: "Alternatively,"

Phrase: "the application of a recently described multimodality strategy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0185125:Application [Health Care Activity]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C3539080:APPLICATION [Quantitative Concept]

Phrase: "(66"

Phrase: ")"

Phrase: ","

Phrase: "combining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0336789:Combine [Manufactured Object]

Phrase: "the sensitivity of optical imaging methods"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "with a modality delivering higher spatial resolution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   836   C1719039:High resolution [Laboratory Procedure]
   804   C1514893:Resolution [Idea or Concept]
   804   C1706463:Resolution [Quantitative Concept]
   804   C2699488:Resolution [Conceptual Entity]

Phrase: "and"

Phrase: "tomographic capabilities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2698977:Capability [Qualitative Concept]

Phrase: "would"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a step toward in vivo use of similar probes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1261552:Step [Conceptual Entity]
   742   C1704379:Step [Functional Concept]
   742   C1705117:Step [Quantitative Concept]
   742   C2825408:Step [Manufactured Object]
Processing 00000000.tx.222: In vivodelivered probes for the detection of apoptosis in intact animals could potentially allow real-time evaluation of cell death and thus circumvent the problems associated with using "frame-by-frame" in situ methods to measure apoptosis, a process that occurs over time. 

Phrase: "In vivodelivered probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "for the detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in intact animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "could"

Phrase: "potentially"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "real-time evaluation of cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2984640:CELL EVALUATION [Functional Concept]
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "thus"

Phrase: "circumvent"

Phrase: "the problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1546466:Problems [Idea or Concept]
   966 E C0033213:Problem [Finding]

Phrase: "associated with using ""frame-"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0080089:Frame [Nucleotide Sequence]
   770   C0180979:Frame [Medical Device]
   770   C1524063:Using [Functional Concept]
   770   C1705858:Frame [Manufactured Object]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   737 E C1947944:Use [Intellectual Product]

Phrase: "by-frame"" in situ methods to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0025663:Methods [Intellectual Product]
   804   C0025664:methods [Intellectual Product]
   804   C0449851:Methods [Functional Concept]
   771 E C0871511:METHOD [Intellectual Product]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "occurs over time."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.223: Such in vivodelivered probes would permit the tracking of the time course of diabetes-associated -cell loss and would expand the range of tools available for study and ultimately for early detection of the disease. 

Phrase: "Such in vivodelivered probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]

Phrase: "would"

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "the tracking of the time course of diabetes-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0546881:Tracking [Spatial Concept]
   711 E C0040594:Track [Manufactured Object]

Phrase: "associated -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "cell loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "would"

Phrase: "expand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "the range of tools"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "available for study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "and"

Phrase: "ultimately for early detection of the disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C2350051:Early Detection of Disease [Diagnostic Procedure]
           Disease Early Detection
   778   C0596473:Early Detection [Diagnostic Procedure]
   774   C0679245:early disease [Temporal Concept]
   774   C0683509:detection disease [Health Care Activity]
   748   C0012634:Disease [Disease or Syndrome]
   748   C1279919:Early [Temporal Concept]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.224: Furthermore, this technique could be used for evaluation of islet viability after transplantation, a therapy for patients with type 1 diabetes that has become more effective in the past few years (67,68). 

Phrase: "Furthermore,"

Phrase: "this technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "used for evaluation of islet viability"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1524063:Use of [Functional Concept]
   753   C0220825:Evaluation [Functional Concept]
   753   C0443348:viability [Qualitative Concept]
   753   C1261322:Evaluation [Health Care Activity]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "after transplantation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029216:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040732:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040733:transplantation [Functional Concept]

Phrase: "a therapy for patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039798:therapy [Functional Concept]
   770   C0087111:Therapy [Therapeutic or Preventive Procedure]
   770   C1363945:Therapy [Finding]

Phrase: "with type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "that"

Phrase: "has"

Phrase: "become"

Phrase: "more effective in the past few years"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:effective [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]

Phrase: "(67,"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.225: The utility of our approach in this scenario is underscored by the evidence that even in optimal conditions and in the absence of graft rejection, 60% of transplanted islet tissue is lost 3 days after transplantation due to cell death (69,70). 

Phrase: "The utility of our approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0582205:utility [Organization]

Phrase: "in this scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683579:scenario [Functional Concept]

Phrase: "is"

Phrase: "underscored by the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "that even in optimal conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C2698651:Optimal [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "and in the absence of graft rejection,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0018129:Graft Rejection [Organ or Tissue Function]
   748   C0035015:Rejection [Social Behavior]
   748   C0181074:{Graft} [Biomedical or Dental Material]
   748   C0332197:absence [Quantitative Concept]
   748   C0332835:Graft [Tissue]
   748   C1515981:And [Idea or Concept]
   748   C1548437:Rejection [Idea or Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1882923:REJECTION [Phenomenon or Process]
   748   C1961139:Graft, NOS [Therapeutic or Preventive Procedure]
   748   C2700401:Rejection [Activity]

Phrase: "60% of transplanted islet tissue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0332835:Transplanted tissue [Tissue]
           transplanted
   797   C0348047:Transplanted tissue, NOS [Tissue]
   760   C0040300:Tissue [Tissue]
   760   C0040732:transplanted [Therapeutic or Preventive Procedure]
   760   C0700106:Transplanted [Functional Concept]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "3 days after transplantation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C1442459:3 Days [Temporal Concept]
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "due to cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "70"

Phrase: ")."
Processing 00000000.tx.226: Still, we need to emphasize that this study only represents a first step toward a potentially novel and valuable imaging strategy, and its true utility as a diagnostic tool remains to be validated.  

Phrase: "Still,"

Phrase: "we"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "emphasize"

Phrase: "that"

Phrase: "this study only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a first step toward a potentially novel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1722730:First Step [Biomedical or Dental Material]
   748   C1261552:Step [Conceptual Entity]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "valuable imaging strategy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategy [Mental Process]

Phrase: "and"

Phrase: "its true utility as a diagnostic tool"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0582205:utility [Organization]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "validated."
Processing 00000000.tx.227: ACKNOWLEDGMENTS  We acknowledge Jennifer Lock (Joslin Diabetes Center) for help with islet isolation and John Moore (Martinos Center) for help with animal handling.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "acknowledge"

Phrase: "Jennifer Lock"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1550024:Lock [Idea or Concept]
   861   C1704783:Lock [Manufactured Object]

Phrase: "(Joslin Diabetes Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: "for"

Phrase: "help with islet isolation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0018896:Help [Social Behavior]
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]
   770   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "John Moore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443030:moore [Intellectual Product]

Phrase: "(Martinos Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: "for"

Phrase: "help with animal handling."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003062:Animal [Animal]
   770   C0018578:Handling [Behavior]
   770   C0018896:Help [Social Behavior]
   770   C1552861:help [Idea or Concept]
   770   C1832073:Handling [Finding]
Processing 00000000.tx.228: FOOTNOTES  The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.229: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.230: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.231: Address correspondence and reprint requests to Anna Moore, PhD, MGH/MIT/HMS Athinoula A. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Anna Moore,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0443030:moore [Intellectual Product]
   770   C0686900:request [Functional Concept]
   770   C1014208:Anna [Plant]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]

Phrase: "PhD,"

Phrase: "MGH/MIT/HMS Athinoula A."
Processing 00000000.tx.232: Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Room 2301, Building 149, 13th St., Charlestown, MA 02129. 

Phrase: "Martinos"

Phrase: "Center for Biomedical Imaging, Department of Radiology,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   778   C0872020:biomedical imaging [Intellectual Product]
   774   C0587500:Radiology department [Health Care Related Organization]
   774   C1708467:Imaging Center [Health Care Related Organization]
   748   C0011923:Imaging [Diagnostic Procedure]
   748   C0034599:Radiology [Biomedical Occupation or Discipline]
   748   C0043299:radiology [Diagnostic Procedure]
   748   C0079595:Imaging [Diagnostic Procedure]
   748   C0205099:Center [Spatial Concept]
   748   C0807679:Radiology [Diagnostic Procedure]
   748   C1704729:Department [Organization]
   748   C1879848:Biomedical [Biomedical Occupation or Discipline]
   748   C1962945:Radiology [Diagnostic Procedure]
   714 E C1704254:Image [Intellectual Product]
   714 E C1704922:Image [Entity]
   714 E C3542466:Image [Intellectual Product]

Phrase: "Massachusetts General Hospital/Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   799   C0036375:School [Manufactured Object,Organization]

Phrase: "Room 2301,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]

Phrase: "Building"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1547706:Building [Functional Concept]
  1000   C1999269:Building [Manufactured Object]
   966 E C1707059:Build [Conceptual Entity]

Phrase: "149,"

Phrase: "13th St., Charlestown,"

Phrase: "MA 02129."
Processing 00000000.tx.233: E-mail: amoore{at}helix.mgh.harvard.edu Received for publication September 13, 2004 and accepted in revised form February 22, 2005 7-AAD, 7-amino-actinomycin; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "amoore{at}helix.mgh.harvard.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication September 13,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2004"

Phrase: "and"

Phrase: "accepted in revised form February 22,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2005 7-AAD,"

Phrase: "7-amino-actinomycin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001259:Actinomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   827   C3536807:Actinomycin [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.234: 99mTc, technetium-99m; 

Phrase: "99mTc,"

Phrase: "technetium-99m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0303611:Technetium 99m [Indicator, Reagent, or Diagnostic Aid]
   861   C0039411:Technetium [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.235: FACS, fluorescence-activated cell sorting; 

Phrase: "FACS,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   861   C0007616:Cell Sorting [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0237886:Sorting [Mental Process]
   812   C0700314:sorting [Cell Function]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1879547:Activated [Activity]
   812   C1947906:Sorting [Activity]
   812   C1948049:Cell [Spatial Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "fluorescence-activated cell sorting"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   861   C0007616:Cell Sorting [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0237886:Sorting [Mental Process]
   812   C0700314:sorting [Cell Function]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1879547:Activated [Activity]
   812   C1947906:Sorting [Activity]
   812   C1948049:Cell [Spatial Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.236: FITC, fluorescein isothiocyanate; 

Phrase: "FITC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: "fluorescein isothiocyanate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.237: H&E, hematoxylin and eosin; 

Phrase: "H&E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "hematoxylin and eosin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.238: MLDS, multiple low-dose streptozotocin; 

Phrase: "MLDS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "multiple low-dose streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: ";"
Processing 00000000.tx.239: NIRF, near-infrared fluorescence; 

Phrase: "NIRF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416389:NIRF [Gene or Genome]
  1000   C1421349:NIRF [Gene or Genome]

Phrase: "near-infrared fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.240: SHDS, single high-dose streptozotocin; 

Phrase: "SHDS,"

Phrase: "single high-dose streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: ";"
Processing 00000000.tx.241: STZ, streptozotocin; 

Phrase: "STZ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: ";"
Processing 00000000.tx.242: TUNEL, transferase-mediated dUTP nick-end labeling  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  OBrien B, Harmon B, Cameron D, Allan D: Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. 

Phrase: "TUNEL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "transferase-mediated dUTP nick-end labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "OBrien B,"

Phrase: "Harmon B,"

Phrase: "Cameron D,"

Phrase: "Allan D"

Phrase: ":"

Phrase: "Beta-cell apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
   734   C0030281:Beta cell [Cell]

Phrase: "is"

Phrase: "responsible for the development of IDDM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "in the multiple low-dose streptozotocin model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]
Processing 00000000.tx.243: J Pathol 178:176181, 1996[Medline] Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, Finegood DT: Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? 

Phrase: "J Pathol 178"

Phrase: ":"

Phrase: "176181,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Trudeau JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Dutz JP,"

Phrase: "Arany E,"

Phrase: "Hill DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Fieldus"

Phrase: "WE,"

Phrase: "Finegood DT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3539739:DT [Gene or Genome]
   861   C3542920:DT [Idea or Concept]

Phrase: ":"

Phrase: "Neonatal beta-cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "a trigger for autoimmune diabetes?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032930:Trigger [Clinical Attribute]
   760   C1444748:Trigger [Qualitative Concept]
Processing 00000000.tx.244: Diabetes 49:17, 2000[Abstract] OBrien BA, Harmon BV, Cameron DP, Allan DJ: Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. 

Phrase: "Diabetes 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "17,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] OBrien BA,"

Phrase: "Harmon BV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511278:BV [Geographic Area]

Phrase: "Cameron DP,"

Phrase: "Allan DJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: ":"

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "the mode of beta-cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1513371:Mode [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]

Phrase: "responsible for the development of IDDM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "in the nonobese diabetic (NOD) mouse."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mouse [Mammal]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.245: Diabetes 46:750757, 1997[Abstract] Saini KS, Thompson C, Winterford CM, Walker NI, Cameron DP: Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "750757,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Saini KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Thompson C,"

Phrase: "Winterford CM,"

Phrase: "Walker NI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "Cameron DP"

Phrase: ":"

Phrase: "Streptozotocin at low doses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and at high doses"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   816   C0444956:High dose [Quantitative Concept]
   770   C0178602:Doses [Quantitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "necrosis in a murine pancreatic beta cell line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0267953:Pancreatic necrosis [Disease or Syndrome]
   744   C0027540:Necrosis [Organ or Tissue Function]
   744   C1334928:Necrosis [Finding]

Phrase: "INS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.246: Biochem Mol Biol Int 39:12291236, 1996[Medline] Zhang Y, OBrien B, Trudeau J, Tan R, Santamaria P, Dutz JP: In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. 

Phrase: "Biochem Mol Biol Int 39"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   804   C0027960:Mole [Neoplastic Process]
   804   C0063789:INT [Organic Chemical]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   804   C3272375:INT [Intellectual Product]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "12291236,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang Y,"

Phrase: "OBrien B,"

Phrase: "Trudeau J,"

Phrase: "Tan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Santamaria P,"

Phrase: "Dutz JP"

Phrase: ":"

Phrase: "In situ beta cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0007587:Cell Death [Cell Function]
   804   C0011065:Death [Organism Function]
   804   C1306577:Death, NOS [Finding]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "priming of diabetogenic CD8 T lymphocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0871133:Priming [Functional Concept]
Processing 00000000.tx.247: J Immunol 168:14661472, 2002[Abstract/Free FullText] Green EA, Eynon EE, Flavell RA: Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. 

Phrase: "J Immunol 168"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "14661472,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Green EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Eynon EE,"

Phrase: "Flavell RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Local expression of TNFalpha"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in neonatal NOD mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0085243:Non-Obese Diabetic Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "diabetes by enhancing presentation of islet antigens."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.248: Immunity 9:733743, 1998[Medline] Kurrer MO, Pakala SV, Hanson HL, Katz JD: Beta cell apoptosis in T cell-mediated autoimmune diabetes. 

Phrase: "Immunity 9"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "733743,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kurrer MO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]

Phrase: "Pakala SV,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013754:SV [Geographic Area]
   861   C0560132:Sv [Quantitative Concept]
   861   C1704677:SV [Idea or Concept]

Phrase: "Hanson HL,"

Phrase: "Katz JD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: ":"

Phrase: "Beta cell apoptosis in T cell-mediated autoimmune diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   810   C1523368:T-cell mediated apoptosis [Cell Function]
   784   C2610891:T cell apoptosis [Cell Function]
   742   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.249: Proc Natl Acad Sci U S A 94:213218, 1997[Abstract/Free FullText] Kagi D, Odermatt B, Ohashi PS, Zinkernagel RM, Hengartner H: Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. 

Phrase: "Proc Natl Acad Sci U S A 94"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "213218,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kagi D,"

Phrase: "Odermatt B,"

Phrase: "Ohashi PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Zinkernagel RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Hengartner H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Development of insulitis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "without diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "perforin-dependent cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.250: J Exp Med 183:21432152, 1996[Abstract/Free FullText] Kagi D, Odermatt B, Seiler P, Zinkernagel RM, Mak TW, Hengartner H: Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. 

Phrase: "J Exp Med 183"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "21432152,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kagi D,"

Phrase: "Odermatt B,"

Phrase: "Seiler P,"

Phrase: "Zinkernagel RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Mak TW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039260:TW [Geographic Area]
   861   C0332293:TW [Therapeutic or Preventive Procedure]

Phrase: "Hengartner H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Reduced incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0021149:Incidence [Quantitative Concept]
   861   C0220856:incidence [Functional Concept]
   789 E C1551358:incident [Idea or Concept]

Phrase: "and"

Phrase: "delayed onset of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332162:Onset [Qualitative Concept]

Phrase: "in perforin-deficient nonobese diabetic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0085243:Non-Obese Diabetic Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   804   C0241863:DIABETIC [Finding]
Processing 00000000.tx.251: J Exp Med 186:989997, 1997[Abstract/Free FullText] Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA Jr, Matis LA: The role of Fas in autoimmune diabetes. 

Phrase: "J Exp Med 186"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "989997,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chervonsky AV,"

Phrase: "Wang Y,"

Phrase: "Wong FS,"

Phrase: "Visintin I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Flavell RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Janeway CA Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Matis LA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: ":"

Phrase: "The role of Fas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in autoimmune diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.252: Cell 89:1724, 1997[Medline] Su X, Hu Q, Kristan JM, Costa C, Shen Y, Gero D, Matis LA, Wang Y: Significant role for Fas in the pathogenesis of autoimmune diabetes. 

Phrase: "Cell 89"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "1724,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Su X,"

Phrase: "Hu Q,"

Phrase: "Kristan JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Costa C,"

Phrase: "Shen Y,"

Phrase: "Gero D,"

Phrase: "Matis LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Wang Y"

Phrase: ":"

Phrase: "Significant role for Fas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of autoimmune diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.253: J Immunol 164:25232532, 2000[Abstract/Free FullText] Eizirik DL, Darville MI: -Cell apoptosis and defense mechanisms: lessons from type 1 diabetes. 

Phrase: "J Immunol 164"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "25232532,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eizirik DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Darville MI"

Phrase: ": -"

Phrase: "Cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "defense mechanisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011142:Defense Mechanisms [Mental Process]
   861   C0441712:Mechanisms [Functional Concept]
   861   C1880266:Defense [Conceptual Entity]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "lessons from type 1 diabetes."
Processing 00000000.tx.254: Diabetes 50 (Suppl. 1):S64S69, 2001[Medline] Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RD, McDevitt HO: Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S64S69,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yang XD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1578656:XD [Functional Concept]
   861   C1704669:XD [Gene or Genome]

Phrase: "Tisch R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Singer SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Cao ZA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037712:ZA [Geographic Area]

Phrase: "Liblau RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Schreiber RD,"

Phrase: "McDevitt HO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832110:HO [Gene or Genome]

Phrase: ":"

Phrase: "Effect of tumor necrosis factor alpha"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   716   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
   716   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
   716   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "on insulin-dependent diabetes mellitus"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in NOD mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.255: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.256: The early development of autoimmunity and the diabetogenic process. 

Phrase: "The early development of autoimmunity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "the diabetogenic process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.257: J Exp Med 180:9951004, 1994[Abstract/Free FullText] von Herrath MG, Oldstone MB: Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. 

Phrase: "J Exp Med 180"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "9951004,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] von Herrath MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Oldstone MB"

Phrase: ":"

Phrase: "Interferon-gamma"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0021740:Interferon Gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0021745:Interferon-gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1149405:interferon-gamma [Molecular Function]
  1000   C2757040:Interferon gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0017011:Gamma [Natural Phenomenon or Process]
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1552644:Gamma [Intellectual Product]
   861   C2349976:Gamma [Quantitative Concept]

Phrase: "is"

Phrase: "essential for destruction of beta cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "development of insulin-dependent diabetes mellitus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
   716   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
Processing 00000000.tx.258: J Exp Med 185:531539, 1997[Abstract/Free FullText] Wang B, Andre I, Gonzalez A, Katz JD, Aguet M, Benoist C, Mathis D: Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. 

Phrase: "J Exp Med 185"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "531539,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang B,"

Phrase: "Andre I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gonzalez A,"

Phrase: "Katz JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Aguet M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Benoist C,"

Phrase: "Mathis D"

Phrase: ":"

Phrase: "Interferon-gamma"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0021740:Interferon Gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0021745:Interferon-gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1149405:interferon-gamma [Molecular Function]
  1000   C2757040:Interferon gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0017011:Gamma [Natural Phenomenon or Process]
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1552644:Gamma [Intellectual Product]
   861   C2349976:Gamma [Quantitative Concept]

Phrase: "impacts at multiple points"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439064:Multiple [Quantitative Concept]
   770   C1825598:IMPACT [Gene or Genome]
   737   C1552961:Point [Quantitative Concept]
   737   C2347617:point [Quantitative Concept]

Phrase: "during the progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "of autoimmune diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.259: Proc Natl Acad Sci U S A 94:1384413849, 1997[Abstract/Free FullText] Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A: -Cell adaptation and decompensation during the progression of diabetes. 

Phrase: "Proc Natl Acad Sci U S A 94"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1384413849,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Weir GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Laybutt DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Kaneto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bonner-Weir S,"

Phrase: "Sharma A"

Phrase: ": -"

Phrase: "Cell adaptation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000934:adaptation [Organism Function]
   861   C0392673:Adaptation [Biologic Function]

Phrase: "and"

Phrase: "decompensation during the progression of diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0231187:Decompensation [Finding]
Processing 00000000.tx.260: Diabetes 50 (Suppl. 1):S154S159, 2001[Medline] Bar-On H, Ben-Sasson R, Ziv E, Arar N, Shafrir E: Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to beta-cell apoptosis. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S154S159,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bar-On H,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0687760:bar [Manufactured Object]
   790   C1551065:bar [Quantitative Concept]

Phrase: "Ben-Sasson R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Ziv E,"

Phrase: "Arar N,"

Phrase: "Shafrir E"

Phrase: ":"

Phrase: "Irreversibility of nutritionally induced NIDDM"

Phrase: "in Psammomys obesus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1013768:Psammomys obesus [Mammal]
   861   C0033783:Psammomys [Mammal]

Phrase: "is"

Phrase: "related to beta-cell apoptosis."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0030281:Beta cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0162638:Apoptosis [Cell Function]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2004068:Beta [Qualitative Concept]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.261: Pancreas 18:259265, 1999[Medline] Donath MY, Gross DJ, Cerasi E, Kaiser N: Hyperglycemia-induced -cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. 

Phrase: "Pancreas 18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "259265,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Donath"

Phrase: "MY,"

Phrase: "Gross DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Cerasi E,"

Phrase: "Kaiser N"

Phrase: ":"

Phrase: "Hyperglycemia-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "induced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "cell apoptosis in pancreatic islets of Psammomys obesus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]

Phrase: "during development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.262: Diabetes 48:738744, 1999[Abstract] Federici M, Hribal M, Perego L, Ranalli M, Caradonna Z, Perego C, Usellini L, Nano R, Bonini P, Bertuzzi F, Marlier LN, Davalli AM, Carandente O, Pontiroli AE, Melino G, Marchetti P, Lauro R, Sesti G, Folli F: High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "738744,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hribal M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Perego L,"

Phrase: "Ranalli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Caradonna Z,"

Phrase: "Perego C,"

Phrase: "Usellini L,"

Phrase: "Nano R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bonini P,"

Phrase: "Bertuzzi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marlier LN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0861352:LN [Neoplastic Process]
   861   C1428884:ln [Gene or Genome]

Phrase: "Davalli"

Phrase: "AM"

Phrase: ","

Phrase: "Carandente O,"

Phrase: "Pontiroli AE,"

Phrase: "Melino G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Marchetti P,"

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sesti G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Folli F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "High glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "apoptosis in cultured human pancreatic islets of Langerhans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]

Phrase: ":"

Phrase: "a potential role for regulation of specific Bcl family genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0680074:family role [Social Behavior]
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "toward an apoptotic cell death program."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1159821:apoptotic program [Cell Function]
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]
   756   C0162638:apoptotic cell death [Cell Function]
Processing 00000000.tx.263: Diabetes 50:12901301, 2001[Abstract/Free FullText] Shimabukuro M, Ohneda M, Lee Y, Unger RH: Role of nitric oxide in obesity-induced beta cell disease. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "12901301,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohneda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee Y,"

Phrase: "Unger RH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: ":"

Phrase: "Role of nitric oxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in obesity-induced beta cell disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.264: J Clin Invest 100:290295, 1997[Abstract/Free FullText] Shimabukuro M, Zhou YT, Levi M, Unger RH: Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "100"

Phrase: ":"

Phrase: "290295,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhou YT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412122:YT [Gene or Genome]

Phrase: "Levi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Unger RH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: ":"

Phrase: "Fatty acid-induced beta cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0162638:Apoptosis [Cell Function]
   727 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "a link between obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.265: Proc Natl Acad Sci U S A 95:24982502, 1998[Abstract/Free FullText] Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY: Distinct effects of saturated and monounsaturated fatty acids on -cell turnover and function. 

Phrase: "Proc Natl Acad Sci U S A 95"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "24982502,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Maedler K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Spinas GA,"

Phrase: "Dyntar D,"

Phrase: "Moritz W,"

Phrase: "Kaiser N,"

Phrase: "Donath"

Phrase: "MY"

Phrase: ":"

Phrase: "Distinct effects of saturated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "monounsaturated fatty acids on -cell turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0031227:turnover [Quantitative Concept]
   799   C0243127:turnover [Functional Concept]
   799   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.266: Diabetes 50:6976, 2001[Abstract/Free FullText] Piro S, Anello M, Di Pietro C, Lizzio MN, Patane G, Rabuazzo AM, Vigneri R, Purrello M, Purrello F: Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "6976,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Piro S,"

Phrase: "Anello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Di Pietro C,"

Phrase: "Lizzio MN,"

Phrase: "Patane G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rabuazzo"

Phrase: "AM"

Phrase: ","

Phrase: "Vigneri R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Purrello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Purrello F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Chronic exposure to free fatty acids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0205191:chronic [Temporal Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "or"

Phrase: "high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in rat pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: ":"

Phrase: "possible role of oxidative stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.267: Metabolism 51:13401347, 2002[Medline] Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. 

Phrase: "Metabolism 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "13401347,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lorenzo A,"

Phrase: "Razzaboni B,"

Phrase: "Weir GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Yankner BA"

Phrase: ":"

Phrase: "Pancreatic islet cell toxicity of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]

Phrase: "associated with type-2 diabetes mellitus."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   882   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   882   C2984301:Type II diabetes mellitus [Functional Concept]
   790   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.268: Nature 368:756760, 1994[Medline] Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H: Amyloid peptides are toxic via a common oxidative mechanism. 

Phrase: "Nature 368"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "756760,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schubert D,"

Phrase: "Behl C,"

Phrase: "Lesley R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Brack A,"

Phrase: "Dargusch R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sagara Y,"

Phrase: "Kimura H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "toxic via a common oxidative mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0600688:toxic [Injury or Poisoning]
   753   C1407029:Toxic [Qualitative Concept]
Processing 00000000.tx.269: Proc Natl Acad Sci U S A 92:19891993, 1995[Abstract/Free FullText] Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. 

Phrase: "Proc Natl Acad Sci U S A 92"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "19891993,"

Phrase: "1995"

Phrase: "[Abstract/Free FullText"

Phrase: "] Janson J,"

Phrase: "Ashley RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Harrison D,"

Phrase: "McIntyre S,"

Phrase: "Butler PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "The mechanism of islet amyloid polypeptide toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "membrane disruption by intermediate-sized toxic amyloid particles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.270: Diabetes 48:491498, 1999[Abstract] Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, Sabatini DD, Ron D: Diabetes mellitus and exocrine pancreatic dysfunction in perk/ mice reveals a role for translational control in secretory cell survival. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "491498,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Harding HP,"

Phrase: "Zeng H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Zhang Y,"

Phrase: "Jungries R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Chung P,"

Phrase: "Plesken H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sabatini DD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: "Ron D"

Phrase: ":"

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "exocrine pancreatic dysfunction in perk/ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C3151951:Exocrine pancreatic dysfunction [Finding]
   753   C0031847:dysfunction [Functional Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a role for translational control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in secretory cell survival."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007620:Cell Survival [Cell Function]
   901   C1519221:Secretory cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.271: Mol Cell 7:11531163, 2001[Medline] Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: -Cell deficit and increased -cell apoptosis in humans with type 2 diabetes. 

Phrase: "Mol Cell 7"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   827   C0007634:Cell [Cell]
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1456781:mole [Neoplastic Process]
   827   C1704653:Cell [Medical Device]
   827   C1824986:mol [Gene or Genome]
   827   C1948049:Cell [Spatial Concept]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "11531163,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Butler AE,"

Phrase: "Janson J,"

Phrase: "Bonner-Weir S,"

Phrase: "Ritzel R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rizza RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Butler PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ": -"

Phrase: "Cell deficit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0162429:Deficit, NOS [Disease or Syndrome]
   861   C2987487:Deficit [Qualitative Concept]

Phrase: "and"

Phrase: "increased -"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cell apoptosis in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.272: Diabetes 52:102110, 2003[Abstract/Free FullText] Reddy S, Bradley J, Ginn S, Pathipati P, Ross JM: Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes. 

Phrase: "Diabetes 52"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "102110,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Reddy S,"

Phrase: "Bradley J,"

Phrase: "Ginn S,"

Phrase: "Pathipati P,"

Phrase: "Ross JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "Immunohistochemical study of caspase-3-expressing cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0557651:Study [Manufactured Object]
   748   C1441616:Immunohistochemical [Laboratory Procedure]
   748   C2603343:Study [Research Activity]

Phrase: "within the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "of non-obese diabetic mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   886   C1513853:NON Mouse [Mammal]
   875   C0025933:Mice, Obese [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0028754:Obese [Disease or Syndrome]
   812   C0241863:DIABETIC [Finding]
   812   C1518422:Non [Functional Concept]

Phrase: "during cyclophosphamide-accelerated diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.273: Histochem Cell Biol 119:451461, 2003[Medline] Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. 

Phrase: "Histochem Cell Biol 119"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "451461,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fadok VA,"

Phrase: "Voelker DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Campbell PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Cohen JJ,"

Phrase: "Bratton DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Henson"

Phrase: "PM"

Phrase: ":"

Phrase: "Exposure of phosphatidylserine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]

Phrase: "on the surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205148:Surface [Spatial Concept]

Phrase: "of apoptotic lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "specific recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524637:Recognition [Mental Process]

Phrase: "and"

Phrase: "removal by macrophages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015252:Removal [Therapeutic or Preventive Procedure]
   790   C0728940:Removal [Therapeutic or Preventive Procedure]
Processing 00000000.tx.274: J Immunol 148:22072216, 1992[Abstract/Free FullText] Verhoven B, Schlegel RA, Williamson P: Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. 

Phrase: "J Immunol 148"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "22072216,"

Phrase: "1992"

Phrase: "[Abstract/Free FullText"

Phrase: "] Verhoven B,"

Phrase: "Schlegel RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Williamson P"

Phrase: ":"

Phrase: "Mechanisms of phosphatidylserine exposure,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "a phagocyte recognition signal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "on apoptotic T lymphocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0039194:T-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.275: J Exp Med 182:15971601, 1995[Abstract/Free FullText] Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. 

Phrase: "J Exp Med 182"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "15971601,"

Phrase: "1995"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vermes I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Haanen C,"

Phrase: "Steffens-Nakken H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Reutelingsperger C"

Phrase: ":"

Phrase: "A novel assay for apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: ":"

Phrase: "flow cytometric detection of phosphatidylserine expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "on early apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "labelled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0181496:Label [Manufactured Object]
   966   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "annexin V."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.276: J Immunol Methods 184:3951, 1995[Medline] Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW: In vivo detection and imaging of phosphatidylserine expression during programmed cell death. 

Phrase: "J Immunol Methods 184"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "3951,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blankenberg FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Katsikis PD,"

Phrase: "Tait JF,"

Phrase: "Davis RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Naumovski L,"

Phrase: "Ohtsuki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kopiwoda S,"

Phrase: "Abrams MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Darkes M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Robbins RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Maecker HT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: "Strauss HW"

Phrase: ":"

Phrase: "In vivo detection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511790:Detection [Therapeutic or Preventive Procedure]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "imaging of phosphatidylserine expression"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0031623:phosphatidylserine [Lipid]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0301704:Phosphatidyl serine [Lipid]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "during programmed cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:Programmed Cell Death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.277: Proc Natl Acad Sci U S A 95:63496354, 1998[Abstract/Free FullText] Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, De Muinck E, Wellens HJ, Kemerink GJ, Reutelingsperger CP, Heidendal GA: Visualisation of cell death in vivo in patients with acute myocardial infarction. 

Phrase: "Proc Natl Acad Sci U S A 95"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "63496354,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hofstra L,"

Phrase: "Liem IH,"

Phrase: "Dumont EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Boersma HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "van Heerde WL,"

Phrase: "Doevendans PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "De Muinck E,"

Phrase: "Wellens HJ,"

Phrase: "Kemerink GJ,"

Phrase: "Reutelingsperger CP,"

Phrase: "Heidendal GA"

Phrase: ":"

Phrase: "Visualisation of cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0175631:Visualization [Mental Process]
   770   C2827662:Visualization [Occupation or Discipline]

Phrase: "in vivo in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "with acute myocardial infarction."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0155626:Acute myocardial infarction [Disease or Syndrome]
  1000   C3541950:ACUTE MYOCARDIAL INFARCTION [Finding]
   901   C0027051:Myocardial Infarction [Disease or Syndrome]
   901   C0428953:MYOCARDIAL INFARCTION [Finding]
   901   C2926063:Myocardial infarction [Clinical Attribute]
   863   C0333548:Acute infarct [Pathologic Function]
   827   C0021308:Infarction [Pathologic Function]
   827   C0027061:Myocardial [Tissue]
   827   C0205178:acute [Temporal Concept]
   827   C1522564:Myocardial [Spatial Concept]
   755 E C0333541:Infarcted [Functional Concept]
Processing 00000000.tx.278: Lancet 356:209212, 2000[Medline] van de Wiele C, Lahorte C, Vermeersch H, Loose D, Mervillie K, Steinmetz ND, Vanderheyden JL, Cuvelier CA, Slegers G, Dierck RA: Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. 

Phrase: "Lancet 356"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "209212,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] van de Wiele C,"

Phrase: "Lahorte C,"

Phrase: "Vermeersch H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Loose D,"

Phrase: "Mervillie K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Steinmetz ND,"

Phrase: "Vanderheyden JL,"

Phrase: "Cuvelier CA,"

Phrase: "Slegers G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Dierck RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Quantitative tumor apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "technetium-99m-HYNIC annexin V single photon emission computed tomography."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   861   C0040399:Tomography, Emission-Computed, Single-Photon [Diagnostic Procedure]
           Single Photon Emission Tomography
   821   C0040398:Tomography, Emission-Computed [Diagnostic Procedure]
   804   C0040405:computed tomography [Diagnostic Procedure]
           tomography
   804   C1552357:Computed Tomography [Professional or Occupational Group]
   790   C0037179:Single [Population Group]
   790   C0040395:tomography [Diagnostic Procedure]
   790   C0086805:Photon [Substance]
   790   C0087136:single [Finding]
   790   C0205171:Single [Quantitative Concept]
   790   C0233929:Emission [Body Substance]
   790   C1441526:Computed [Laboratory Procedure]
   790   C1880157:Computed [Activity]
   790   C2349995:Emission [Substance]
Processing 00000000.tx.279: J Clin Oncol 21:34833487, 2003[Abstract/Free FullText] Boersma HH, Liem IH, Kemerink GJ, Thimister PW, Hofstra L, Stolk LM, van Heerde WL, Pakbiers MT, Janssen D, Beysens AJ, Reutelingsperger CP, Heidendal GA: Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5. 

Phrase: "J Clin Oncol 21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "34833487,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Boersma HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Liem IH,"

Phrase: "Kemerink GJ,"

Phrase: "Thimister PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Hofstra L,"

Phrase: "Stolk LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "van Heerde WL,"

Phrase: "Pakbiers MT,"

Phrase: "Janssen D,"

Phrase: "Beysens AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Reutelingsperger CP,"

Phrase: "Heidendal GA"

Phrase: ":"

Phrase: "Comparison between human pharmacokinetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "imaging properties of two conjugation methods"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "for 99mTc-annexin A5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0059249:annexin A5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332095:ANNEXIN A5 [Gene or Genome]
Processing 00000000.tx.280: Br J Radiol 76:553560, 2003[Abstract/Free FullText] Schellenberger EA, Bogdanov A Jr, Hogemann D, Tait J, Weissleder R, Josephson L: Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. 

Phrase: "Br J Radiol 76"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0628037:BR 76 [Organic Chemical]
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "553560,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schellenberger EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Bogdanov"

Phrase: "A Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Hogemann D,"

Phrase: "Tait J,"

Phrase: "Weissleder R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Josephson L"

Phrase: ":"

Phrase: "Annexin V-CLIO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1915069:Clio [Eukaryote]
   734   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332095:ANNEXIN V [Gene or Genome]

Phrase: ":"

Phrase: "a nanoparticle for detecting apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1450054:Nanoparticle [Manufactured Object]

Phrase: "by MRI."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024485:MRI [Diagnostic Procedure]
  1000   C1824234:MRI [Gene or Genome]
Processing 00000000.tx.281: Mol Imaging 1:102107, 2002[Medline] Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A Jr: Near-infrared fluorescent imaging of tumor apoptosis. 

Phrase: "Mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "102107,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Petrovsky A,"

Phrase: "Schellenberger E,"

Phrase: "Josephson L,"

Phrase: "Weissleder R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bogdanov"

Phrase: "A Jr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: ":"

Phrase: "Near-infrared fluorescent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "imaging of tumor apoptosis."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0162638:Apoptosis [Cell Function]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.282: Cancer Res 63:19361942, 2003[Abstract/Free FullText] Schellenberger EA, Bogdanov A Jr, Petrovsky A, Ntziachristos V, Weissleder R, Josephson L: Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. 

Phrase: "Cancer Res 63"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "19361942,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schellenberger EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Bogdanov"

Phrase: "A Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Petrovsky A,"

Phrase: "Ntziachristos V,"

Phrase: "Weissleder R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Josephson L"

Phrase: ":"

Phrase: "Optical imaging of apoptosis"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]
   715   C0042789:Vision [Organism Function]
   715   C2707266:Vision [Clinical Attribute]

Phrase: "as a biomarker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Biomarker [Clinical Attribute]

Phrase: "of tumor response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C3539879:Tumor Response [Idea or Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "to chemotherapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
  1000   C0013217:chemotherapy [Functional Concept]
  1000   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.283: Neoplasia 5:187192, 2003[Medline] Montana E, Bonner-Weir S, Weir GC: Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. 

Phrase: "Neoplasia 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027651:Neoplasia [Neoplastic Process]
   789 E C1709160:Neoplastic [Qualitative Concept]

Phrase: ":"

Phrase: "187192,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Montana E,"

Phrase: "Bonner-Weir S,"

Phrase: "Weir GC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: ":"

Phrase: "Beta cell mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   734   C0030281:Beta cell [Cell]

Phrase: "and"

Phrase: "growth after syngeneic islet cell transplantation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0007595:Cell Growth [Cell Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]

Phrase: "in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "streptozocin diabetic C57BL/6 mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   873   C1521751:C57BL/6 Mouse [Mammal]
   853   C0025921:Mice, C57BL [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.284: J Clin Invest 91:780787, 1993[Medline] Cardinal JW, Margison GP, Mynett KJ, Yates AP, Cameron DP, Elder RH: Increased susceptibility to streptozotocin-induced beta-cell apoptosis and delayed autoimmune diabetes in alkylpurine-DNA-N-glycosylase-deficient mice. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "91"

Phrase: ":"

Phrase: "780787,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cardinal JW,"

Phrase: "Margison GP,"

Phrase: "Mynett KJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439255:kJ [Quantitative Concept]

Phrase: "Yates AP,"

Phrase: "Cameron DP,"

Phrase: "Elder RH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: ":"

Phrase: "Increased susceptibility to streptozotocin-induced beta-cell apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0012655:Susceptibility [Clinical Attribute]
   744   C0220898:Susceptibility [Organism Attribute]
   744   C1264642:Susceptibility [Functional Concept]
   744   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "and"

Phrase: "delayed autoimmune diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in alkylpurine-DNA-N-glycosylase-deficient mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   734   C1417239:ALKYLPURINE DNA N-GLYCOSYLASE [Gene or Genome]
   700   C0171226:alkylpurine N-glycosylase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.285: Mol Cell Biol 21:56055613, 2001[Abstract/Free FullText] George M, Ayuso E, Casellas A, Costa C, Devedjian JC, Bosch F: Beta cell expression of IGF-I leads to recovery from type 1 diabetes. 

Phrase: "Mol Cell Biol 21"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "56055613,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] George M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ayuso E,"

Phrase: "Casellas A,"

Phrase: "Costa C,"

Phrase: "Devedjian JC,"

Phrase: "Bosch F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Beta cell expression of IGF-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to recovery"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C0237820:Recovery [Activity]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "from type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.286: J Clin Invest 109:11531163, 2002[Abstract/Free FullText] Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D: Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "109"

Phrase: ":"

Phrase: "11531163,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoglund P,"

Phrase: "Mintern J,"

Phrase: "Waltzinger C,"

Phrase: "Heath W,"

Phrase: "Benoist C,"

Phrase: "Mathis D"

Phrase: ":"

Phrase: "Initiation of autoimmune diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0589507:Initiation [Mental Process]
   770   C1158830:Initiation [Genetic Function]
   770   C1704686:Initiation [Functional Concept]

Phrase: "by developmentally regulated presentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449450:Presentation [Idea or Concept]

Phrase: "of islet cell antigens"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0003320:Antigens [Immunologic Factor]
   734   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   734   C1522529:Islet Cell [Cell]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "in the pancreatic lymph nodes."
Meta Candidates (Total=15; Excluded=9; Pruned=0; Remaining=6)
  1000   C0229783:Pancreatic lymph nodes [Body Part, Organ, or Organ Component]
           Pancreatic nodes
   966 E C1280901:Pancreatic lymph node [Body Part, Organ, or Organ Component]
   901   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   867 E C0440747:LYMPH NODE [Tissue]
   867 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   827   C0024202:Lymph [Body Substance]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0746922:nodes [Body Part, Organ, or Organ Component]
   793 E C1706163:Node [Conceptual Entity]
   793 E C2697524:Node [Conceptual Entity]
   793 E C2700445:Node [Plant]
   743 E C0443268:Nodal [Spatial Concept]
   743 E C1417752:NODAL [Gene or Genome]
   721 E C0449725:Nodality [Spatial Concept]
Processing 00000000.tx.287: J Exp Med 189:331339, 1999[Abstract/Free FullText] Katz JD, Benoist C, Mathis D: T helper cell subsets in insulin-dependent diabetes. 

Phrase: "J Exp Med 189"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "331339,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Katz JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Benoist C,"

Phrase: "Mathis D"

Phrase: ":"

Phrase: "T helper cell subsets in insulin-dependent diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0080202:subsets t-cell [Cell]
   711   C1515021:Subset [Classification]
Processing 00000000.tx.288: Science 268:11851188, 1995[Medline] Stratmann T, Martin-Orozco N, Mallet-Designe V, Poirot L, McGavern D, Losyev G, Dobbs CM, Oldstone MB, Yoshida K, Kikutani H, Mathis D, Benoist C, Haskins K, Teyton L: Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. 

Phrase: "Science 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "11851188,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stratmann T,"

Phrase: "Martin-Orozco N,"

Phrase: "Mallet-Designe V,"

Phrase: "Poirot L,"

Phrase: "McGavern D,"

Phrase: "Losyev G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Dobbs CM,"

Phrase: "Oldstone MB,"

Phrase: "Yoshida K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kikutani H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mathis D,"

Phrase: "Benoist C,"

Phrase: "Haskins K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Teyton L"

Phrase: ":"

Phrase: "Susceptible MHC alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "not background genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "an autoimmune T cell reactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   741   C0205332:Reactive [Qualitative Concept]
Processing 00000000.tx.289: J Clin Invest 112:902914, 2003[Abstract/Free FullText] Turley S, Poirot L, Hattori M, Benoist C, Mathis D: Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "112"

Phrase: ":"

Phrase: "902914,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Turley S,"

Phrase: "Poirot L,"

Phrase: "Hattori M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Benoist C,"

Phrase: "Mathis D"

Phrase: ":"

Phrase: "Physiological beta cell death triggers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0032930:triggers [Clinical Attribute]
   771 E C1444748:Trigger [Qualitative Concept]

Phrase: "priming of self-reactive T cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0039194:T-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0036588:Self [Idea or Concept]
   753   C0205332:Reactive [Qualitative Concept]
   753   C0871133:Priming [Functional Concept]
   753   C1551994:self [Intellectual Product]
   753   C3244295:Self [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "by dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in a type-1 diabetes model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C3161035:Model [Intellectual Product]
   756   C0011854:Type 1 diabetes [Disease or Syndrome]
   708   C1320657:type diabetes [Finding]
Processing 00000000.tx.290: J Exp Med 198:15271537, 2003[Abstract/Free FullText] Gagnerault MC, Luan JJ, Lotton C, Lepault F: Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. 

Phrase: "J Exp Med 198"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "15271537,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gagnerault MC,"

Phrase: "Luan JJ,"

Phrase: "Lotton C,"

Phrase: "Lepault F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Pancreatic lymph nodes"
Meta Candidates (Total=15; Excluded=9; Pruned=0; Remaining=6)
  1000   C0229783:Pancreatic lymph nodes [Body Part, Organ, or Organ Component]
           Pancreatic nodes
   966 E C1280901:Pancreatic lymph node [Body Part, Organ, or Organ Component]
   901   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   867 E C0440747:LYMPH NODE [Tissue]
   867 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   827   C0024202:Lymph [Body Substance]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0746922:nodes [Body Part, Organ, or Organ Component]
   793 E C1706163:Node [Conceptual Entity]
   793 E C2697524:Node [Conceptual Entity]
   793 E C2700445:Node [Plant]
   743 E C0443268:Nodal [Spatial Concept]
   743 E C1417752:NODAL [Gene or Genome]
   721 E C0449725:Nodality [Spatial Concept]

Phrase: "are"

Phrase: "required for priming of beta cell reactive T cells"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0030281:Beta cell [Cell]
   764   C0039194:T-Cells [Cell]
   742   C0007634:Cell [Cell]
           Cells
   742   C0205332:Reactive [Qualitative Concept]
   742   C0330390:Beta [Plant]
   742   C0439096:Beta [Intellectual Product]
   742   C0871133:Priming [Functional Concept]
   742   C1269647:Cell [Cell]
   742   C1514873:Required [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2004068:Beta [Qualitative Concept]
   742   C3282337:Cells [Cell]

Phrase: "in NOD mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.291: J Exp Med 196:369377, 2002[Abstract/Free FullText] Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, Homann D, Beaudoin L, Schrike C, Von Herrath M, Lehuen A, Glaichenhaus N: Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. 

Phrase: "J Exp Med 196"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "369377,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hugues S,"

Phrase: "Mougneau E,"

Phrase: "Ferlin W,"

Phrase: "Jeske D,"

Phrase: "Hofman P,"

Phrase: "Homann D,"

Phrase: "Beaudoin L,"

Phrase: "Schrike C,"

Phrase: "Von Herrath M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Lehuen A,"

Phrase: "Glaichenhaus N"

Phrase: ":"

Phrase: "Tolerance to islet antigens"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0013220:Tolerance [Finding]
   770   C0020963:Tolerance [Pathologic Function]
   770   C0220929:tolerance [Mental Process]
   770   C0231197:Tolerance [Physiologic Function]
   770   C1704410:Tolerance [Qualitative Concept]
   715 E C0680282:toleration [Social Behavior]

Phrase: "and"

Phrase: "prevention from diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1659987:diabetes prevention [Educational Activity]
   790   C0199176:Prevention [Therapeutic or Preventive Procedure]
   790   C1706420:PREVENTION [Research Activity]
   790   C2700409:prevention [Qualitative Concept]

Phrase: "induced by limited apoptosis of pancreatic beta cells."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   806   C3157088:pancreatic beta cell apoptosis [Cell Function]
   800   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   744   C0007634:Cells [Cell]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0162638:Apoptosis [Cell Function]
   744   C0205263:Induced [Functional Concept]
   744   C0330390:Beta [Plant]
   744   C0439096:Beta [Intellectual Product]
   744   C0439801:Limited [Functional Concept]
   744   C2004068:Beta [Qualitative Concept]
   744   C3282337:Cells [Cell]
   744   C3542948:Limited [Intellectual Product]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.292: Immunity 16:169181, 2002[Medline] Leiter EH, Coleman DL, Hummel KP: The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. 

Phrase: "Immunity 16"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "169181,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Leiter EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Coleman DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Hummel KP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022772:KP [Geographic Area]
   861   C1881334:kp [Quantitative Concept]

Phrase: ":"

Phrase: "The influence of genetic background"

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "at the diabetes locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "in the mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.293: III. 

Phrase: "III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]
Processing 00000000.tx.294: Effect of H-2 haplotype and sex. 

Phrase: "Effect of H-2 haplotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "sex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]
Processing 00000000.tx.295: Diabetes 30:10291034, 1981[Abstract] Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontana A, Kaiser N, Donath MY: Glucose induces -cell apoptosis via upregulation of the Fas receptor in human islets. 

Phrase: "Diabetes 30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "10291034,"

Phrase: "1981"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Maedler K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Spinas GA,"

Phrase: "Lehmann R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sergeev P,"

Phrase: "Weber M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fontana A,"

Phrase: "Kaiser N,"

Phrase: "Donath"

Phrase: "MY"

Phrase: ":"

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induces -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell apoptosis via upregulation of the Fas receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1326205:up-regulation of apoptosis [Cell Function]
   744   C0162638:Apoptosis [Cell Function]

Phrase: "in human islets."
Processing 00000000.tx.296: Diabetes 50:16831690, 2001[Abstract/Free FullText] Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY: Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "16831690,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Maedler K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sergeev P,"

Phrase: "Ris F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Oberholzer J,"

Phrase: "Joller-Jemelka HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0018619:HI [Geographic Area]
   827   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   827   C1412082:HI [Gene or Genome]
   827   C1412316:HI [Gene or Genome]

Phrase: "Spinas GA,"

Phrase: "Kaiser N,"

Phrase: "Halban PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Donath"

Phrase: "MY"

Phrase: ":"

Phrase: "Glucose-induced beta cell production of IL-1beta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1819435:IL-1 beta production [Organism Function]
   744   C0033268:production [Occupational Activity]

Phrase: "contributes to glucotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880177:Contribute [Activity]

Phrase: "in human pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.297: J Clin Invest 110:851860, 2002[Abstract/Free FullText] Maedler K, Fontana A, Ris F, Sergeev P, Toso C, Oberholzer J, Lehmann R, Bachmann F, Tasinato A, Spinas GA, Halban PA, Donath MY: FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "110"

Phrase: ":"

Phrase: "851860,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Maedler K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fontana A,"

Phrase: "Ris F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Sergeev P,"

Phrase: "Toso C,"

Phrase: "Oberholzer J,"

Phrase: "Lehmann R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bachmann F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Tasinato A,"

Phrase: "Spinas GA,"

Phrase: "Halban PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Donath"

Phrase: "MY"

Phrase: ":"

Phrase: "FLIP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413357:FLIP [Gene or Genome]
  1000   C3272498:FLIP [Gene or Genome]

Phrase: "switches"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707719:SWITCHES [Manufactured Object]

Phrase: "Fas-mediated glucose signaling in human pancreatic beta cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C0037083:Cell Signaling [Cell Function]
           Signaling
   742   C3537152:signaling [Biologic Function]

Phrase: "from apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "to cell replication."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0007590:cell replication [Cell Function]
   861   C0598312:Replication [Genetic Function]
   861   C1883725:replication [Qualitative Concept]
   789 E C0205173:Replicate [Functional Concept]
   789 E C0205341:Replicate [Functional Concept]
Processing 00000000.tx.298: Proc Natl Acad Sci U S A 99:82368241, 2002[Abstract/Free FullText] Donath MY, Halban PA: Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. 

Phrase: "Proc Natl Acad Sci U S A 99"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "82368241,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Donath"

Phrase: "MY,"

Phrase: "Halban PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: ":"

Phrase: "Decreased beta-cell mass in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: ":"

Phrase: "significance,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "therapeutic implications."
Processing 00000000.tx.299: Diabetologia 47:581589, 2004[Medline] Mathis D, Vence L, Benoist C: Beta-cell death during progression to diabetes. 

Phrase: "Diabetologia 47"

Phrase: ":"

Phrase: "581589,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mathis D,"

Phrase: "Vence L,"

Phrase: "Benoist C"

Phrase: ":"

Phrase: "Beta-cell death during progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0007587:Cell Death [Cell Function]
   760   C0011065:Death [Organism Function]
   760   C1306577:Death, NOS [Finding]

Phrase: "to diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.300: Nature 414:792798, 2001[Medline] Bellone M, Iezzi G, Rovere P, Galati G, Ronchetti A, Protti MP, Davoust J, Rugarli C, Manfredi AA: Processing of engulfed apoptotic bodies yields T cell epitopes. 

Phrase: "Nature 414"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "792798,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bellone M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Iezzi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rovere P,"

Phrase: "Galati G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ronchetti A,"

Phrase: "Protti MP,"

Phrase: "Davoust J,"

Phrase: "Rugarli C,"

Phrase: "Manfredi AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: ":"

Phrase: "Processing of engulfed apoptotic bodies"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C3269134:apoptotic body [Cell Component]
   781   C0162638:Apoptotic Process [Cell Function]
   760   C0242821:bodies [Human]
   760   C1516044:Apoptotic [Qualitative Concept]
   760   C1709694:Processing [Activity]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]
   726 E C1268086:Body [Anatomical Structure]
   726 E C1522240:Process [Phenomenon or Process]

Phrase: "yields"

Phrase: "T cell epitopes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282580:T-Cell Epitopes [Immunologic Factor]
   827   C0003316:Epitopes [Immunologic Factor]
   734   C0039194:T-cell [Cell]
Processing 00000000.tx.301: J Immunol 159:53915399, 1997[Abstract] Kown MH, Strauss HW, Blankenberg FG, Berry GJ, Stafford-Cecil S, Tait JF, Goris ML, Robbins RC: In vivo imaging of acute cardiac rejection in human patients using 99mtechnetium labeled annexin V. 

Phrase: "J Immunol 159"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "53915399,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kown MH,"

Phrase: "Strauss HW,"

Phrase: "Blankenberg FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Berry GJ,"

Phrase: "Stafford-Cecil S,"

Phrase: "Tait JF,"

Phrase: "Goris ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Robbins RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "In vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "imaging of acute cardiac rejection"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   797   C3273245:Acute Rejection [Finding]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   760   C0035015:Rejection [Social Behavior]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0205178:acute [Temporal Concept]
   760   C1522601:Cardiac [Spatial Concept]
   760   C1548437:Rejection [Idea or Concept]
   760   C1882923:REJECTION [Phenomenon or Process]
   760   C2700401:Rejection [Activity]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "in human patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "99mtechnetium"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "annexin V."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.302: Am J Transplant 1:270277, 2001[Medline] Hofstra L, Dumont EA, Thimister PW, Heidendal GA, DeBruine AP, Elenbaas TW, Boersma HH, van Heerde WL, Reutelingsperger CP: In vivo detection of apoptosis in an intracardiac tumor. 

Phrase: "Am"

Phrase: "J Transplant 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040732:Transplant [Therapeutic or Preventive Procedure]
   827   C0332835:Transplant [Tissue]

Phrase: ":"

Phrase: "270277,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hofstra L,"

Phrase: "Dumont EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Thimister PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Heidendal GA,"

Phrase: "DeBruine AP,"

Phrase: "Elenbaas TW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039260:TW [Geographic Area]
   861   C0332293:TW [Therapeutic or Preventive Procedure]

Phrase: "Boersma HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "van Heerde WL,"

Phrase: "Reutelingsperger CP"

Phrase: ":"

Phrase: "In vivo detection of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in an intracardiac tumor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
Processing 00000000.tx.303: J Am Med Assoc 285:18411842, 2001[Free FullText] Kemerink GJ, Boersma HH, Thimister PW, Hofstra L, Liem IH, Pakbiers MT, Janssen D, Reutelingsperger CP, Heidendal GA: Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans. 

Phrase: "J"

Phrase: "Am"

Phrase: "Med Assoc 285"

Phrase: ":"

Phrase: "18411842,"

Phrase: "2001"

Phrase: "[Free FullText"

Phrase: "] Kemerink GJ,"

Phrase: "Boersma HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Thimister PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Hofstra L,"

Phrase: "Liem IH,"

Phrase: "Pakbiers MT,"

Phrase: "Janssen D,"

Phrase: "Reutelingsperger CP,"

Phrase: "Heidendal GA"

Phrase: ":"

Phrase: "Biodistribution"

Phrase: "and"

Phrase: "dosimetry of 99mTc-BTAP-annexin-V"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0034603:Dosimetry [Laboratory Procedure]
   716   C1122906:99mTc-BTAP-annexin-V [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.304: Eur J Nucl Med 28:13731378, 2001[Medline] Kemerink GJ, Liem IH, Hofstra L, Boersma HH, Buijs WC, Reutelingsperger CP, Heidendal GA: Patient dosimetry of intravenously administered 99mTc-annexin V. 

Phrase: "Eur J Nucl Med 28"

Phrase: ":"

Phrase: "13731378,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kemerink GJ,"

Phrase: "Liem IH,"

Phrase: "Hofstra L,"

Phrase: "Boersma HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Buijs WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Reutelingsperger CP,"

Phrase: "Heidendal GA"

Phrase: ":"

Phrase: "Patient dosimetry of intravenously administered 99mTc-annexin V."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0034603:Dosimetry [Laboratory Procedure]
Processing 00000000.tx.305: J Nucl Med 42:382387, 2001[Abstract/Free FullText] Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, Steinmetz ND, Vanderheyden JL, Green AM, Verbeke K: Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. 

Phrase: "J Nucl Med 42"

Phrase: ":"

Phrase: "382387,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kemerink GJ,"

Phrase: "Liu X,"

Phrase: "Kieffer D,"

Phrase: "Ceyssens S,"

Phrase: "Mortelmans L,"

Phrase: "Verbruggen"

Phrase: "AM"

Phrase: ","

Phrase: "Steinmetz ND,"

Phrase: "Vanderheyden JL,"

Phrase: "Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "AM"

Phrase: ","

Phrase: "Verbeke K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Safety,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036043:Safety [Human-caused Phenomenon or Process]
  1000   C1705187:SAFETY [Research Activity]

Phrase: "biodistribution,"

Phrase: "and"

Phrase: "dosimetry of 99mTc-HYNIC-annexin V,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0034603:Dosimetry [Laboratory Procedure]

Phrase: "a novel human recombinant annexin V for human application."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1332095:ANNEXIN V [Gene or Genome]
   762   C0231966:V A [Clinical Attribute]
   742   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.306: J Nucl Med 44:947952, 2003[Abstract/Free FullText] Post AM, Katsikis PD, Tait JF, Geaghan SM, Strauss HW, Blankenberg FG: Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. 

Phrase: "J Nucl Med 44"

Phrase: ":"

Phrase: "947952,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Post"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0687676:Post [Temporal Concept]
  1000   C1704687:Post [Manufactured Object]
   928 E C1514253:Postal [Functional Concept]

Phrase: "AM"

Phrase: ","

Phrase: "Katsikis PD,"

Phrase: "Tait JF,"

Phrase: "Geaghan SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Strauss HW,"

Phrase: "Blankenberg FG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: ":"

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "cell death with radiolabeled annexin V"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "in an experimental model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086272:Experimental Model [Intellectual Product]
   861   C3161035:Model [Intellectual Product]

Phrase: "of rheumatoid arthritis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.307: J Nucl Med 43:13591365, 2002[Abstract/Free FullText] Tokita N, Hasegawa S, Maruyama K, Izumi T, Blankenberg FG, Tait JF, Strauss HW, Nishimura T: 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. 

Phrase: "J Nucl Med 43"

Phrase: ":"

Phrase: "13591365,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tokita N,"

Phrase: "Hasegawa S,"

Phrase: "Maruyama K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Izumi T,"

Phrase: "Blankenberg FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Tait JF,"

Phrase: "Strauss HW,"

Phrase: "Nishimura T"

Phrase: ":"

Phrase: "99mTc-Hynic-annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "apoptosis in rats"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "with autoimmune myocarditis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027059:Myocarditis [Disease or Syndrome]
   861   C1962971:Myocarditis [Finding]
Processing 00000000.tx.308: Eur J Nucl Med Mol Imaging 30:232238, 2003[Medline] Yang DJ, Azhdarinia A, Wu P, Yu DF, Tansey W, Kalimi SK, Kim EE, Podoloff DA: In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V. 

Phrase: "Eur J Nucl Med Mol"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   875   C2346604:J/mol [Quantitative Concept]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "30"

Phrase: ":"

Phrase: "232238,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yang DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Azhdarinia A,"

Phrase: "Wu P,"

Phrase: "Yu DF,"

Phrase: "Tansey W,"

Phrase: "Kalimi SK,"

Phrase: "Kim EE,"

Phrase: "Podoloff DA"

Phrase: ":"

Phrase: "In vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro measurement of apoptosis in breast cancer cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0242485:Measurement [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "99mTc-EC-annexin V."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0969148:99mTc-EC-annexin V [Organic Chemical,Pharmacologic Substance]
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.309: Cancer Biother Radiopharm 16:7383, 2001[Medline] Mochizuki T, Kuge Y, Zhao S, Tsukamoto E, Hosokawa M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N: Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V. 

Phrase: "Cancer Biother Radiopharm 16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006826:Cancer [Neoplastic Process]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: ":"

Phrase: "7383,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mochizuki T,"

Phrase: "Kuge Y,"

Phrase: "Zhao S,"

Phrase: "Tsukamoto E,"

Phrase: "Hosokawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strauss HW,"

Phrase: "Blankenberg FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Tait JF,"

Phrase: "Tamaki N"

Phrase: ":"

Phrase: "Detection of apoptotic tumor response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in vivo after a single dose of chemotherapy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "with 99mTc-annexin V."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332095:ANNEXIN V [Gene or Genome]
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.310: J Nucl Med 44:9297, 2003[Abstract/Free FullText] Ntziachristos V, Tung CH, Bremer C, Weissleder R: Fluorescence molecular tomography resolves protease activity in vivo. 

Phrase: "J Nucl Med 44"

Phrase: ":"

Phrase: "9297,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ntziachristos V,"

Phrase: "Tung CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Bremer C,"

Phrase: "Weissleder R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Fluorescence molecular tomography"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]

Phrase: "resolves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699488:Resolve [Conceptual Entity]

Phrase: "protease activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150095:protease activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.311: Nat Med 8:757760, 2002[Medline] Moore A, Medarova Z, Potthast A, Dai G: In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. 

Phrase: "Nat Med 8"

Phrase: ":"

Phrase: "757760,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moore A,"

Phrase: "Medarova Z,"

Phrase: "Potthast A,"

Phrase: "Dai G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "In vivo targeting of underglycosylated MUC-1 tumor antigen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1516015:Antigen Targeting [Molecular Function]
   742   C1521840:Targeting [Functional Concept]
   708 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a multimodal imaging probe."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C1513743:Multimodal Imaging [Diagnostic Procedure]
   827   C0011923:Imaging [Diagnostic Procedure]
   827   C0079595:Imaging [Diagnostic Procedure]
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]
   793 E C1704254:Image [Intellectual Product]
   793 E C1704922:Image [Entity]
   793 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.312: Cancer Res 64:18211827, 2004[Abstract/Free FullText] Shapiro A, Lakey J, Ryan E, Korbutt G, Toth E, Warnock G, Kneteman N, Rajotte R: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. 

Phrase: "Cancer Res 64"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "18211827,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shapiro A,"

Phrase: "Lakey J,"

Phrase: "Ryan E,"

Phrase: "Korbutt G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Toth E,"

Phrase: "Warnock G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kneteman N,"

Phrase: "Rajotte R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Islet transplantation in seven patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0079646:Transplantation, Islet [Therapeutic or Preventive Procedure]
   760   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040733:transplantation [Functional Concept]

Phrase: "with type 1 diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011854:Diabetes Mellitus, Type 1 [Disease or Syndrome]
           Type 1 diabetes
  1000   C2984334:Type I diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441729:Type 1 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a glucocorticoid-free immunosuppressive regimen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040808:Regimen [Therapeutic or Preventive Procedure]
   812   C2945654:regimen [Intellectual Product]
Processing 00000000.tx.313: N Engl J Med 343:230238, 2000[Abstract/Free FullText] Shapiro A, Ricordi C, Hering B: Edmontons islet success has indeed been replicated elsewhere. 

Phrase: "N Engl J Med 343"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "230238,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shapiro A,"

Phrase: "Ricordi C,"

Phrase: "Hering B"

Phrase: ":"

Phrase: "Edmontons islet success"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0597535:Success [Social Behavior]
   755 E C1272703:Successful [Qualitative Concept]

Phrase: "has"

Phrase: "indeed"

Phrase: "been"

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "elsewhere."
Processing 00000000.tx.314: Lancet 362:1242, 2003 Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E: -Cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. 

Phrase: "Lancet 362"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "1242,"

Phrase: "2003 Biarnes M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Montolio M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nacher V,"

Phrase: "Raurell M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Soler J,"

Phrase: "Montanya E"

Phrase: ": -"

Phrase: "Cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "mass in syngeneically transplanted islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]

Phrase: "exposed to short-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C1282927:short [Qualitative Concept]
   790   C1806781:Short [Quantitative Concept]
   790   C2350002:Short [Quantitative Concept]

Phrase: "and"

Phrase: "long-term hyperglycemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020456:Hyperglycaemia [Disease or Syndrome]
   734   C0443252:Long-term [Temporal Concept]
Processing 00000000.tx.315: Diabetes 51:6672, 2002[Abstract/Free FullText] Davalli A, Scaglia L, Zangen D, Hollister J, Bonner-Weir S, Weir G: Vulnerability of islets in the immediate posttransplantation period: dynamic changes in structure and function. 

Phrase: "Diabetes 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "6672,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Davalli A,"

Phrase: "Scaglia L,"

Phrase: "Zangen D,"

Phrase: "Hollister J,"

Phrase: "Bonner-Weir S,"

Phrase: "Weir G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Vulnerability of islets"

Phrase: "in the immediate posttransplantation period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: ":"

Phrase: "dynamic changes in structure"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.316: Diabetes 45:11611167, 1996[Abstract] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Medarova, Z. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "11611167,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Request Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Medarova,"

Phrase: "Z."
Processing 00000000.tx.317: Articles by Moore, A. 

Phrase: "Articles by Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.318: Articles citing this Article PubMed PubMed Citation Articles by Medarova, Z. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Medarova,"

Phrase: "Z."
Processing 00000000.tx.319: Articles by Moore, A. 

Phrase: "Articles by Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.320: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum DOC News

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Diabetes Diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0039224:Table [Manufactured Object]
   738   C1706073:Table [Medical Device]
   738   C1706074:Table [Intellectual Product]

Phrase: "Care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "Clinical Diabetes Diabetes Spectrum DOC News"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0282425:News [Intellectual Product]

